Fertility and Sterility

Short telomeres in the chromosomes of spare eggs predict poor prognosis following in vitro fertilization/embryo transfer-toward a telomere theory of reproductive aging in women
pp. 1-1(1)
Authors: Keefe D.L.; Franco S.; Liu L.; Trimarchi J.; Blasco M.; Weitzen S.

Establishment of mouse male germ line stem cells (GSCs) and in vitro differentiation to haploid germ cells
pp. 1-1(1)
Authors: Lee D.R.; Kim S.K.; Cha K.Y.; Yang Y.H.; Yoon T.K.; Kim K.S.

Stampidine: A potential nonspermicidal broad-spectrum anti-HIV microbicide
pp. 1-2(2)
Authors: D'Cruz O.J.; Uckun F.M.

Premenstrual GnRH antagonist administration coordinates early antral follicle sizes and sets up bases for an innovative controlled ovarian hyperstimulation (COH) concept
pp. 2-3(2)
Authors: Fanchin R.; Branco A.C.; Kadoch I.J.; Hosny G.; Torrisi C.; Frydman R.

Interleukin-10 levels in single embryo conditioned media samples help predict implantation
pp. 2-2(1)
Authors: Retzloff M.G.; Combelles C.M.H.; Bowman F.P.; Racowsky C.; Schust D.J.

Questionnaire on self-perception and behavior of adolescent girls with polycystic ovary syndrome (PCOS)
pp. 3-3(1)
Authors: Yoo R.Y.; Adams J.; Chang R.J.

Defective autophosphorylation of the insulin receptor (APIR): a potential mechanism of insulin resistance in polycystic ovary syndrome (PCOS)
pp. 3-4(2)
Authors: Mor E.; Zograbyan A.; Zhang C.; Bayrak A.; Stanczyk F.Z.; Paulson R.J.

Overexpression of P160 steroid receptor coactivators (SRCs) in endometrial cancer
pp. 4-4(1)
Authors: Groll J.M.; Brown A.L.; Apparao K.B.C.; Gregory C.W.; Wilson E.M.; Lessey B.A.

De novo testosterone production in a luteinizing hormone receptor knockout mouse after transplantation of Leydig stem cells
pp. 4-4(1)
Authors: Lo K.C.; Lei Z.M.; Rao C.V.; Lamb D.J.

Evaluation of men with unilateral or bilateral undescended testes: Does age of correction make a difference?
pp. 4-5(2)
Authors: Stuart A.L.; Schoor R.; Caroppo E.; Hanbly S.E.; Ross L.; Niederberger C.

A comparison of ejaculatory success rates and sperm parameters in patients with acute versus chronic spinal cord injury (SCI)
pp. 5-5(1)
Authors: Grotas J.A.; Lynne C.M.; Aballa T.C.; Brackett N.L.

Epididymal obstruction results in isolated sperm heads in post-vasectomy rats
pp. 5-5(1)
Authors: Khaira H.S.; Schuster T.D.; Zhang W.-X.; Dunn R.L.; Smith G.D.; Ohl D.A.

Ligation of the C1q receptor, gC1qR/p33, associates with both the _v3 integrin and vitronectin and causes protein phosphorylation
pp. 5-6(2)
Authors: Grace K.S.; Bronson R.A.; Ghebrehiwet B.

Single dose nasal spray of gonadotropin releasing hormone (GnRH) agonist effectively matures oocytes for in vitro fertilization in an ovarian stimulation protocol using clomiphene citrate, gonadotropin, and GnRH antagonist
pp. 6-6(1)
Authors: Goto T.; Oka C.; Tomiyama T.; Mukaida T.; Takahashi K.

Autologous endometrial co-culture (AECC): an effective tool for patients with multiple failed IVF attempts
pp. 6-6(1)
Authors: Spandorfer S.D.; Clark R.; Park J.; Veeck L.; Rosenwaks Z.

Orthotopic autotransplantation of ovarian cortex
pp. 7-7(1)
Authors: Sanchez M.; Reis S.; Gadea B.; Alama P.; Escriba M.-J.; Pellicer A.

Adverse IVF outcome with increased junctional zone contractions frequency on the day of hCG administration
pp. 7-7(1)
Authors: Zahalka N.; Weissman A.; Farhi J.; Malinger G.; Glezerman M.; Levran D.

How long is necessary to achieve complete cytoplasmic maturation after nuclear maturation in human oocytes?
pp. 7-7(1)
Authors: Cha J.-H.; Hyun C.-S.; Son W.-Y.; Yoon S.-H.; Lim J.-H.

FSH coasting combined with recombinant LH: a novel stimulation approach for ART
pp. 8-8(1)
Authors: Hazout A.; Junca A.M.; Bacrie P.C.

The rate of triploid zygotes (3PN) after intracytoplasimic sperm injection (ICSI) is related to the number of days of stimulation
pp. 8-8(1)
Authors: Rosen M.P.; Dobson A.T.; Shen S.; Telles T.L.; Fujimoto V.Y.; Cedars M.I.

Endometrial impact of GnRH agonists and antagonists during the window of implantation in controlled ovarian hyperstimulation cycles
pp. 8-9(2)
Authors: Mirkin S.; Bocca S.; Hsiu J.G.; Nikas Y.; Gosden R.; Oehninger S.

No need for dose adjustment of GnRH antagonist based on patient's body weight in controlled ovarian hyperstimulation with recombinant follicle stimulating hormone
pp. 9-9(1)
Authors: Oberye J.; Study Group on Weight Adjusted Dosing of Ganirelix

Improving the accuracy of genetic diagnosis from single cells through analysis of real-time PCR signal kinetics
pp. 9-9(1)
Authors: Pierce K.E.; Rice J.E.; Sanchez A.; Wangh L.J.

Antibodies toward proacrosin/acrosin in infertile women
pp. 10-10(1)
Authors: Veaute C.; Furlong L.I.; Bronson R.; Vazquez-Levin M.H.

Leptin regulates the expression of leukemia inhibitory factor by human endometrial cells
pp. 10-10(1)
Authors: Gonzalez R.R.; Rueda B.R.; Ramos M.P.; Littell R.D.; Glasser S.R.; Leavis P.C.

Human decidua expresses retinol binding protein: Its regulation by retinoic acid
pp. 10-10(1)
Authors: Sbracia M.; Poverini R.; Scarpellini F.

Progesterone (P4) exposure alters expression of T-bet, a transcription factor involved in Th1/Th2 modulation
pp. 11-11(1)
Authors: Ashby R.K.; Patel R.N.; Schust D.J.

Polymorphisms in the promoter of the TNFa gene are not associated with recurrent pregnancy loss and TNFa serum levels in a Caucasian population of 380 women
pp. 11-11(1)
Authors: Tempfer C.B.; Unfried G.; Nagele F.; Hefler L.A.; Riener E.-K.; Pietrowski D.

The presence of human papilloma virus (HPV) is negatively associated with IVF outcome
pp. 11-11(1)
Authors: Spandorfer S.D.; Rosenwaks Z.; Paraskevas L.; Bongiovanni A.M.; Witkin S.

Recurrent pregnancy loss and diminished ovarian reserve measured as day 3 serum inhibin B concentrations
pp. 11-12(2)
Authors: Coulam C.B.; Roussev R.G.

Gamma-Interferon and IL-2 receptor levels predict the outcome of IVF pregnancies
pp. 12-12(1)
Authors: Fasouliotis S.J.; Spandorfer S.D.; Witkin S.; Liu H.; Bongiovanni A.-M.; Rosenwaks Z.

Soluble HLA-G (sHLA-G) in human embryo culture media: a useful marker for assessing embryo quality, and implantation potential for IVF
pp. 12-13(2)
Authors: Roussev R.; Keskintepe L.; Coulam C.; Sher G.; Maasarani G.

The effect of leukemia inhibitory factor on production of tissue inhibitor of metalloprotease-1 and -2
pp. 13-13(1)
Authors: Ozornek H.; Koldovsky U.

''Contrast ultrasound'' of uterine cavity made easy and practical through a novel phase-shifting, contrast-enhancing medium
pp. 13-13(1)
Author: Ziegler D.d.

Endometrial volume versus endometrial thickness: Which one is a better predictor of optimal endometrial receptivity in ART?
pp. 13-14(2)
Authors: Tur-Kaspa I.; Meltzer S.; Segal O.; Rabinson J.; Segal S.; Zohav E.

A novel optically transparent, phase-shifting medium permits direct endoscopic vision of the uterine cavity without requiring the infusion of fluid or gas
pp. 14-14(1)
Author: Ziegler D.d.

Endometrial volume and early ART pregnancy outcome
pp. 14-14(1)
Authors: Tur-Kaspa I.; Segal O.; Rabinson J.; Meltzer S.; Segal S.; Zohav E.

Pregnancy rates of blastocyst-staged embryos are reduced if transferred to an endometrium classified as grade B by transvaginal ultrasound
pp. 14-15(2)
Authors: Potlog-Nahari C.; Catherino W.C.H.; Wesley R.; Nieman L.K.; Segars J.H.; McKeeby J.

Defining the menopausal transition: A new definition to detect early hormonal changes in women
pp. 15-15(1)
Authors: Gracia C.R.; Sammel M.D.; Freeman E.W.; Liu L.; Langan E.; Nelson D.

The Factor V Leiden polymorphism is associated with early menopause in Cucasian women
pp. 15-15(1)
Authors: Riener E.-K.; Tempfer C.B.; Hefler L.A.; Schneeberger C.; Huber J.C.

Identification of osteoporosis risk in postmenopausal women by the combined use of ultrasounds and clinical factors
pp. 15-16(2)
Authors: Omodei U.; Benussi C.; Feller M.; Decca L.; Gambacciani M.

Safety and efficacy of conjugated estrogens (CE)/trimegestone (TMG) on vasomotor symptoms, vaginal atrophy, and metabolic profiles in a double-blind, randomized, placebo-controlled study
pp. 16-16(1)
Authors: Lobo R.A.; Dorin M.H.; Lewis V.; Simon J.A.; Grubb G.S.

The relationship between interleukin-1 and its receptor antagonist gene polymorphism and bone mineral density in postmenopausal Korean women
pp. 16-16(1)
Authors: Kim J.; Kim S.; Ku S.; Choi Y.; Moon S.

Estrogen therapy does not improve cognitive function in early menopause
pp. 16-17(2)
Authors: Krikorian R.; Welge J.A.; Shidler M.D.; Muse K.; Liu J.H.

Effect of conjugated estrogens (CE)/trimegestone (TMG) on bone mineral density (BMD) in early postmenopausal women in a double-blind, randomized, placebo-controlled study
pp. 17-17(1)
Authors: Lindsay R.; Gallagher J.C.; Harrison D.D.; Zinaman M.J.; Pickar J.H.

A comparison of the antiatherogenic properties of phytoestrogen with those of estradiol using an ovariectomized cholesterol-fed rabbit model
pp. 17-18(2)
Authors: Haines C.J.; James A.E.; Sahota D.S.; Chen Z.Y.; Panesar N.S.; Tomlinson B.

Impact of conjugated estrogens (CE)/trimegestone (TMG) on endometrial hyperplasia and bleeding profiles in a double-blind, randomized, placebo-controlled study
pp. 18-18(1)
Authors: Pickar J.H.; Yeh I.-T.; Cunnane M.F.; Archer D.F.

Effect of estradiol and progesterone on cardiac protein synthesis in female rats
pp. 18-18(1)
Authors: Goldstein J.S.; Sites C.K.; Toth M.J.

Intracellular ATP as a regulator of calcium oscillations in fertilized mouse oocytes
pp. 18-19(2)
Authors: Igarashi H.; Takahashi T.; Takahashi E.; Kurachi H.

Application of green fluorescent protein (GFP) for the construction of genetically modified endometrial tissue
pp. 19-19(1)
Authors: Liu H.-C.; He Z.; Rosenwaks Z.

Development of bioassays using the bovine model to measure the efficiency of SCNT in humans
pp. 19-20(2)
Authors: Zavos P.M.; Illmensee K.

Transcriptional regulation of the Luteinizing Hormone Beta-Subunit (LH) gene by Ptx1
pp. 20-20(1)
Authors: Halvorson L.M.; Horton C.D.; Kaiser U.B.; He Z.; Jeong K.-H.

Cell type-specific expression and regulation of neuropilin-1 and -2 in the rhesus macaque endometrium suggests roles for VEGF-Neuropilin in endometrial remodeling during the menstrual cycle in primates
pp. 20-20(1)
Authors: Germeyer A.; Brenner R.M.; Kao L.C.; Giudice L.C.; Nayak N.R.

Enhanced hatching of mouse embryos by prostacyclin corresponded to the stage-specific expression of prostacyclin receptor by the mouse embryos
pp. 21-21(1)
Authors: Huang J.-C.; Wun W.-S.A.; Goldsby J.S.; Wun I.C.; Falconi S.M.; Wu K.K.

Birth of a rhesus monkey after transplantation of ovarian tissue
pp. 21-21(1)
Authors: Lee D.M.; Yeoman R.; Battaglia D.E.; Stouffer R.L.; Fanton J.; Wolf D.P.

Follicular and corpus luteum angiogenesis does not involve recruitment of bone marrow-derived endothelial progenitor cells through activated VEGF receptor 1
pp. 21-22(2)
Authors: Mendonca H.; Vorontchikhina M.; Bohlen P.; Sauer M.V.; Kitajewski J.; Zimmermann R.C.

VEGF/VEGF receptor 2 pathway is critical for normal function of the corpora lutea of pregnancy, but not for early embryonic development
pp. 22-22(1)
Authors: Pauli S.A.; Wang J.; Chu M.C.; Bohlen P.; Sauer M.V.; Zimmermann R.C.

Exposure of preimplantation stage embryos to platelet-activating factor increases birth rate and weight
pp. 22-23(2)
Authors: Roudebush W.E.; Massey J.B.; Kort H.I.; Toledo A.A.; Mitchell-Leef D.; Elsner C.W.

Relationship between growth factors and the embryotoxicity of hydrosalpingeal fluid
pp. 23-23(1)
Authors: Bedaiwy M.A.; Goldberg J.M.; Said T.M.; Barber M.; Sharma R.K.; Falcone T.

Screening of novel expressed sequence tags in pluripotent human embryonic stem cells using suppression-subtractive hybridization
pp. 23-23(1)
Authors: Juan D.; Ge L.; Yueqiu T.; Guangxiu L.

Superparamagnetic extraction of ejaculated human spermatozoa with early apoptotic changes
pp. 23-24(2)
Authors: Paasch U.; Agarwal A.; Sharma R.K.; Grunewald S.; Thomas A.J.; Glander H.-J.

Effect of zona manipulation on somatic cell nucleus transfer
pp. 24-24(1)
Authors: Findikli N.; Kahraman S.; Donmez E.; Sertyel S.; Melil S.

Meichroacidin, a novel morn repeat family member localizes within the axoneme of human sperm and is a human alloantigen
pp. 24-25(2)
Authors: Shetty J.; Wolkowicz M.J.; Klotz K.L.; Herr J.C.

Time to pregnancy: results of the German prospective study and impact on the management of infertility
pp. 25-25(1)
Authors: Gnoth C.; Godehardt D.; Godehardt E.; Frank-Herrmann P.; Freundl G.

A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. A preliminary result
pp. 25-25(1)
Author: Al-Fozan H.

Intranasal administration (IN) of leuprolide to healthy women
pp. 25-26(2)
Authors: Muse K.N.; Archer S.; Iqbal K.; Fisher A.

Progestogen effects on mood and cognition in early menopause
pp. 26-26(1)
Authors: Krikorian R.; Welge J.A.; Shidler M.D.; Muse K.; Liu J.H.

The impact of the ACGME workweek requirements on resident participation in REI clinics and surgical cases
pp. 26-26(1)
Authors: Feinberg E.C.; Milad M.P.

Deciphering early folliculogenesis: Jun Amino Terminal Kinase (JNK) plays a key role in preantral follicle growth
pp. 26-27(2)
Authors: Oktay K.H.; Buyuk E.; Oktem O.; Oktay M.; Rosenwaks Z.; Giancotti F.

Suspension culture of intact ovarian follicles maintains spherical three-dimensional structure better than traditional tissue culture
pp. 27-27(1)
Authors: McGee E.A.; Rowgani N.; Heise M.; McKeel D.; Koepsel R.; Russell A.

Acrogranin (Granulin Epithelin Precursor, PCDFG) is crucial for mouse embryo receptivity and implantation
pp. 27-28(2)
Authors: Perez C.M.; Diaz-cueto L.; Van der voort D.; Schwarze J.E.; Gerton G.L.

Low-dose LH administration induces ovulation and prevents vascular hyperpermeability and VEGF expression in superovulated rats
pp. 28-28(1)
Authors: Gomez R.; Lima I.; Simon C.; Pellicer A.

Expression and functional analysis of forkhead L2 (FOXL2), the gene involved in premature ovarian failure
pp. 28-28(1)
Authors: Pisarska M.D.; Bae J.; Hsueh A.J.W.

The effect of varicocelectomy on serum hormonal levels in infertile men with clinical varicoceles
pp. 29-29(1)
Authors: Pasqualotto F.F.; Lucon A.M.; Goes P.M.; Hallak J.; Pasqualotto E.B.; Arap S.

Improved detection of cystic fibrosis mutations in at-risk patients with DNA sequence analysis
pp. 29-29(1)
Authors: Danziger K.L.; Black L.D.; Keiles S.; Turek P.J.

Screening of the SPO11 and EIF5A2 genes in a population of azoospermic and severely oligozoospermic men
pp. 29-30(2)
Authors: Christensen G.L.; Ivanov I.P.; Atkins J.F.; Schlegel P.; Mielnik A.; Carrell D.T.

New semen collection technique/container improves semen quality
pp. 30-30(1)
Authors: Johnson D.; Prien S.D.

The risk of epididymal injury during hydrocelectomy and spermatocelectomy
pp. 30-30(1)
Authors: Zahalsky M.P.; Nagler H.M.

Roles for caspases in human spermatozoa: a marker for sperm quality?
pp. 30-31(2)
Authors: Morshedi M.S.; Taylor S.L.; Weng S.-L.; Duran H.; Beebe S.J.; Oehninger S.

Spermatozoa mitochondrial ferritin (MtF) content is related to sperm motility
pp. 31-31(1)
Authors: Calzi F.; Levi S.; Santambrogio P.; Santis L.D.; Rabellotti E.; Bonzi V.

Gene expression profiles during mouse spermatogenesis by 8.0K cDNA microarray experiment
pp. 31-31(1)
Authors: Lee S.; Park J.H.; Kim K.-S.; Kim H.-J.; Cha K.Y.; Lee S.-H.

The broad-spectrum chemokine inhibitor NR58-3.14.3 suppresses the implantation and progression of human endometrial implants in the nude mice endometriosis model
pp. 31-32(2)
Authors: Berkkanoglu M.; Zhang L.; Kayisli U.A.; Senturk L.; Luk J.; Arici A.

Cox 2 selective inhibitor prevents the implantaion of eutopic endometrium to ectopic sites in rats
pp. 32-32(1)
Authors: Matsuzaki S.; Canis M.; Darcha C.; Yaegashi N.; Okamura K.; Mage G.

Bee propolis versus placebo in the treatment of infertility associated with minimal or mild endometriosis: A pilot randomized controlled trial. A modern trend
pp. 32-32(1)
Authors: Ali A.F.M.; Awadallah A.

Antioxidant supplementation reduces total chemokines and inflammatory cytokines in women with endometriosis
pp. 32-33(2)
Authors: Santanam N.; Kavtaradze N.; Dominguez C.; Rock J.A.; Parthasarathy S.; Murphy A.A.

Estrogen regulates MCP-1 in endometrial cells differently in women with endometriosis and may involve a non-genomic pathway
pp. 33-33(1)
Authors: Halis G.; Taskiran S.A.; Kayisli U.A.; Arici A.

Molecular profiling of endometriosis using tissue microarrays: Disease correlation with increased expression of estrogen receptor- (ER-) and decreased expression of progesterone receptor (PR)
pp. 33-33(1)
Authors: Kamat A.A.; Simpson J.L.; Agoulnik A.I.

Expression and mitogenic effect of fibroblast growth factor-9 in human endometriotic implant is regulated by aberrant production of estrogen
pp. 34-34(1)
Authors: Wu M.-H.; Chuang P.-C.; Chen H.-M.; Tsai S.-J.

EBAF/Lefty-1 antagonizes progesterone action in human endometrium and in experimental endometriosis
pp. 34-34(1)
Authors: Bruner-Tran K.L.; Tabibzadeh S.; Cornet P.B.; Henriet P.; Eisenberg E.; Osteen K.G.

Proteomic patterns in plasma and peritoneal fluid of women with endometriosis
pp. 34-35(2)
Authors: Ferrero S.; Gillott D.J.; Remorgida V.; Anserini P.; Ragni N.; Grudzinskas G.J.

P53 perturbations in endometriosis detected by quantitative real-time PCR: further evidence of late somatic DNA alterations
pp. 35-35(1)
Authors: Bischoff F.Z.; Dang D.; Poindexter A.; Mitchell-Leef D.; Buster J.E.; Simpson J.L.

The hysteroscopic correction of an incomplete uterine septum may have a positive impact on IVF outcome
pp. 35-35(1)
Authors: Ozgur K.; Isikoglu M.; Oehninger S.; Donmez L.

The effect of myomectomy on in vitro fertilization-embryo transfer (IVF-ET) cycle outcome: the oocyte donation model
pp. 35-36(2)
Authors: Surrey E.S.; Minjarez D.A.; Stevens J.M.; Schoolcraft W.B.

Abdominal myomectomy: Risk factors for intraoperative and postoperative complications
pp. 36-36(1)
Authors: Montgomery B.E.; Glassner M.J.; Dunton C.J.

Asherman's syndrome: Etiologic factors, patterns of pregnancy loss, and treatment results. Results from an international registry
pp. 36-37(2)
Authors: Palter S.F.; Spyrou P.

The presence of interstitial cystitis in patients with ovarian remnant syndrome or residual ovarian syndrome
pp. 37-37(1)
Authors: Chung M.K.; Butrick C.W.; Chung R.P.; Shriver J.S.

BhCG doubling time in early gestation in symptomatic patients with an intrauterine pregnancy: the curves redefined
pp. 37-37(1)
Authors: Barnhart K.T.; Rinaudo P.F.; Sammel M.D.; Zhou L.; Guo W.; Hummel A.

Comparison of daily ganirelix administration to a long protocol agonist for controlled ovarian hyperstimulation in oocyte donors: The results of a prospective randomized controlled trial
pp. 37-38(2)
Authors: Shamma F.N.; Grossman M.P.; Abuzeid M.I.; al-Hosn L.; Ayers J.W.T.; Fakih M.H.

Apoptosis of human peritoneal and adhesion fibroblasts after hypoxia: Role of inducible nitric oxide synthase
pp. 38-38(1)
Authors: Saed G.M.; Abu-Soud H.M.; Diamond M.P.

Comparison of ionophore induced Ca2+ release in fresh and cryopreserved oocytes
pp. 38-38(1)
Authors: Jones A.E.; Blerkom J.V.; Toledo A.A.; Davis P.

Evaluation of mouse MII oocyte survival after treatment by two different vitrification methods
pp. 39-39(1)
Authors: Urcia E.M.; Thorsell L.P.; Blauer K.L.

Identification and class assignment proteins expressed during mouse oocyte development using proteomics strategy
pp. 39-39(1)
Authors: Gosden R.G.; Yin H.; Miller D.; Platts A.; Bell A.; Boulay B.

Quantification of the common deletion in mitochondrial DNA of ICSI-Amniocytes and Non-ICSI-Amniocytes by competitive PCR
pp. 39-40(2)
Authors: Lee S.H.; Cho S.W.; Kim H.A.; Kwak I.P.; Han J.E.; Cha K.Y.

Assisted conception in serodiscordant couples in whom the man is HIV+ using a strict protocol for semen processing and testing
pp. 40-40(1)
Authors: Morshedi M.; Bocca S.; Diaz J.; Oehninger S.; Nehchiri F.; Muasher S.

Does the zona pellucida select fertilizing spermatozoa for the ova or serve as a nonspecific barrier to the inseminated sperm cell population?
pp. 40-40(1)
Authors: Kuehl T.J.; Hudson S.B.A.; Wincek T.J.; Pliego J.F.

A retrospective analysis of factors influencing oocyte degeneration post-ICSI
pp. 40-41(2)
Authors: Davis A.; Richter K.S.; Graham J.; Carter J.; Kearns W.G.; Tucker M.J.

Co-culture of embryos with novel human endometrial cell line in transwell dishes promotes embryo development without cell contact
pp. 41-41(1)
Authors: Desai N.; Lawson J.; Goldfarb J.

Statistically significant correlation between normal sperm morphology (NSM) and sperm binding potential to an immobilized monolayer of hyaluronan using the HYDAK(r) sperm hyaluronan-binding assay (HBA)
pp. 41-42(2)
Authors: Worrilow K.C.; Belcak N.; Maher N.; Bower J.B.; Peters A.J.; Johnston J.B.

Meiotic spindle formation and checkpoint function during haploidization of somatic nuclei
pp. 42-42(1)
Authors: Chang C.-C.; Nagy Z.P.; Tian X.C.; Abdelmassih R.; Yang X.

In vitro fertilization within microfluidic channels requires lower total numbers and lower concentrations of spermatozoa
pp. 42-42(1)
Authors: Suh R.S.; Phadke N.; Ohl D.A.; Takayama S.; Smith G.D.

Mevastatin inhibits ovarian theca-interstitial cell proliferation and testosterone production
pp. 42-43(2)
Authors: Izquierdo D.; Foyouzi N.; Kwinkiewicz J.; Duleba A.

Identification of human testis-specific gene SRG5 by digital differential display
pp. 43-43(1)
Authors: Dan L.; Guangxiu L.; YaQin M.; JunJiang F.; XiaoWei X.; Gang L.

Tyroxine hydroxylase (TH) downregulation in hyperstimulated ovaries reveals the dopamine agonist bromocriptine (Br2) as an effective and specific method to block increased vascular permeability (VP) in OHSS
pp. 43-44(2)
Authors: Gomez R.; Gonzalez M.; Simon C.; Remohi J.; Pellicer A.

Identification of a mouse GnRH gene promoter element that mediates ovarian (but not hypothalamic) GnRH expression in vivo
pp. 44-44(1)
Authors: Kim H.H.; Wolfe A.; Nash C.J.; Radovick S.

Potential of anastrozole for release of endogenous FSH
pp. 44-44(1)
Authors: Tredway D.; Buraglio M.; Hemsey G.; Denton G.

Short courses of metformin alter the endocrine profile of patients with polycystic ovary syndrome
pp. 44-45(2)
Authors: Helliwell J.P.; Bonpane C.M.; Katz S.; Khorram O.

The effect of combination therapy of metformin with combined oral contraceptives (COC) versus COC monotherapy in PCOS patients: a randomized study
pp. 45-45(1)
Authors: Cibula D.; Fanta M.; Vrbikova J.; Hill M.; Skrenkova J.; Zivny J.

Effects of chromium supplementation on insulin sensitivity and reproductive function in polycystic ovarian syndrome: A pilot study
pp. 45-46(2)
Authors: Lydic M.L.; McNurlan M.; Komaroff E.; Mitchell L.; Bembo S.; Gelato M.

Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS) using age-specific DHEAS levels adjusted for body mass and ethnicity
pp. 46-46(1)
Authors: Kumar A.; Bartolucci A.A.; Azziz R.

Increased 17-hydroxyprogesterone (17P) responsiveness to gonadotropin stimulation in hyperthecosis (HT) compared to polycystic ovary syndrome (PCOS)
pp. 46-46(1)
Authors: Dahan M.H.; Coffler M.S.; Patel K.S.; Yoo R.Y.; Malcom P.J.; Chang R.J.

Tattoo of the non-palpable testis mass: A new way to use intra-operative ultrasound guided needle localization for management of non-palpable testicular lesions
pp. 46-47(2)
Author: Seaman E.K.

Testicular sperm extraction with intracytoplasmic sperm injection is successful in the treatment of non-obstructive azoospermia associated with cryptorchidism
pp. 47-47(1)
Authors: Raman J.D.; Schlegel P.

Comparison of two tese procedures and PGD outcomes for patients with Klinefelter's syndrome
pp. 47-47(1)
Authors: Bakircioglu M.E.; Kahraman S.; Sertyel S.; Findikli N.; Berkil H.; Unal S.

In vitro spermatogenesis of the mice in the collagen gel matrix
pp. 47-48(2)
Authors: Lee J.-H.; Kim H.K.; Lee S.J.; Choi K.-W.; Lee S.J.

Incidence and seminal characteristics of AZF gene deletions in an infertile, African-American male population
pp. 48-48(1)
Authors: Witt M.A.; Lotspeich R.

Randomized double blind placebo controlled trial of carnitine for the treatment of idiopathic asthenospermia
pp. 48-48(1)
Authors: Pryor J.L.; Glass S.L.; Campagnone J.; Sigman M.

Acrosome activity is lower in sperm from men with spinal cord injury compared to age-matched, healthy control subjects
pp. 48-48(1)
Authors: Bruck D.S.; Aballa T.C.; Lynne C.M.; Brackett N.L.

Predictive value of strict criteria sperm morphology for intrauterine insemination outcomes
pp. 48-49(2)
Authors: Sparks A.E.T.; Voorhis B.J.V.; Holz L.R.; Dokras A.; Davis W.A.; Syrop C.H.

Parents' conceptualization of their frozen embryos complicates the disposition decision
pp. 49-49(1)
Authors: Nachtigall R.; Becker G.; Tober D.; Friese C.; Butler A.

Disclosure attitudes among known and anonymous oocyte donation recipients
pp. 49-50(2)
Authors: Klock S.C.; Greenfeld D.A.

Going it alone: Solo mothers and their donor insemination (DI) infants
pp. 50-50(1)
Authors: Murray C.E.; Golombok S.E.

Psychological characteristics of egg donors: MMPI-2 profiles of 436 anonymous oocyte donor candidates
pp. 50-50(1)
Authors: Riddle M.P.; Applegarth L.; Josephs L.; Grill E.; Cholst I.; Rosenwaks Z.

Families created through surrogacy: Parent-child relationships in the first year of life
pp. 50-50(1)
Authors: Golombok S.E.; Murray C.E.

September 11th in New York City (NYC): the effect of a catastrophe on IVF outcome in a New York City based program
pp. 51-51(1)
Authors: Spandorfer S.D.; Grill E.; Davis O.; Fasouliotis S.J.; Rosenwaks Z.

Psychological distress by type of fertility problem
pp. 51-51(1)
Authors: Jacob M.C.; McQuillan J.; Greil A.L.; White L.

A comparison of IVF outcome among women who take antidepressants with those who do not
pp. 51-52(2)
Authors: Klock S.C.; Sheinin S.; Zhang J.

Male infertility patients' perceived utility and satisfaction with genetic counseling services
pp. 52-52(1)
Authors: Powis Z.; Pfeifer K.; Yates C.; Ormond K.; Calhoun E.A.; Brannigan R.E.

Oral contraceptive treatment in polycystic ovarian syndrome improves mental health
pp. 52-52(1)
Authors: Krikorian R.; Elkind-Hirsch K.; Chang R.J.

The role of angiogenesis on irregular bleeding of women using three types of intra uterine devices
pp. 52-53(2)
Authors: Tustas E.; Oral E.; Ilvan S.

Progressive tissue exclusion of a proximal sterilization micro-insert from the uterine cavity: a hysteroscopic and photographic assessment
pp. 53-53(1)
Authors: Kerin J.F.; Rosen D.M.

The effect of mifepristone on estrogen receptors following treatment with medroxyprogesterone acetate in cultured human endometrial explants
pp. 53-53(1)
Authors: Nucatola D.L.; Li A.; Nicosia A.F.; Felix J.C.; Jain J.K.

Contraceptive ring compliance: as labeled versus calendar based use
pp. 54-54(1)
Authors: Ballagh S.A.; Babb T.A.; Kovalevsky G.; Archer D.F.

Developmental toxicology studies of WHI-07, a novel nucleoside analogue-based dual-function microbicide
pp. 54-54(1)
Authors: D'Cruz O.J.; Erbeck D.; Uckun F.M.

Early luteal endometrial phase can rescue early stage blastocyts
pp. 54-55(2)
Authors: Escriba M.-J.; Galan A.; Gamiz P.; Zulategui J.; Pellicer A.; Remohi J.

Day 3 transfer leads to the higher miscarriage rates in patients with 5 or less fertilized oocytes
pp. 55-55(1)
Authors: Abdelmassih V.; Oliveira F.G.; Goncalves S.P.; Diamond M.P.; Abdelmassih R.; Dozortzev D.

Vaginal versus intramuscular progesterone in oocyte donation replacement therapy
pp. 55-55(1)
Authors: Caligara C.; Ruiz S.; Terrero M.; Mantrana E.; Calderon G.; Navarro J.

Single sperm cryopreservation on cryoloops: an alternative to hamster zona for cryopreservation of individual spermatozoa
pp. 55-56(2)
Authors: Desai N.; Blackmon H.; Goldfarb J.

Pregnancy derived from human nuclear transfer
pp. 56-56(1)
Authors: Zhang J.; Zhuang G.; Zeng Y.; Acosta C.; Shu Y.; Grifo J.

Junctional zone contractions during zygote intrafallopian transfer
pp. 56-56(1)
Authors: Levran D.; Zahalka N.; Malinger G.; Farhi J.; Glezerman M.; Weissman A.

Blastocyst formation after intracytoplasmic sperm injection (ICSI) and culture in two sequential culture media preparations differing with respect to the method of protein supplementation
pp. 56-57(2)
Authors: Rahil T.; Brody S.A.; Butler M.T.; Ho M.N.; Rousseau M.F.; Scull J.

Better embryo quality and reproductive performance using sequential media in day 3 transfers
pp. 57-57(1)
Authors: Bisioli C.; Valcarcel A.; Tiveron M.; Quintana R.; Young E.; Sueldo C.

Effect of sperm treatments on neonatal outcome and development of ICSI children
pp. 57-58(2)
Authors: Neri Q.V.; Squires J.; Williams-Pitman M.; Wang A.; Rosenwaks Z.; Palermo G.D.

Autologous endometrial co-culture (AECC) in patients with IVF failure: correlations of outcome with IGF-1
pp. 58-58(1)
Authors: Spandorfer S.D.; Fasouliotis S.; Park J.; Witkin S.; Rosenwaks Z.

Frequency of aneuploidy among women with poor prognosis and recurrent implantation failure
pp. 58-58(1)
Authors: Pagidas K.; Ying Y.; Trimarchi J.; Hackett R.J.; Keefe D.L.

Treatment of _V3 integrin abnormalities increases pregnancy success rates after failed IVF cycles
pp. 58-59(2)
Authors: Farrell R.; Gray D.; Gindlesperger V.; Arredondo F.; Liu J.; Loret de Mola J.R.

Mannose Binding Lectin (MBL) gene polymorphism and in vitro fertilization outcome
pp. 59-59(1)
Authors: Spandorfer S.D.; Paraskevas L.; Rosenwaks Z.; Witkin S.

The IVF low responder: do not rush to cancel
pp. 59-60(2)
Authors: Ryley D.A.; Regan M.; Connolly C.; Harris D.; Klipstein S.; Reindollar R.H.

Anonymous oocyte donation: what is the most efficient use of this limited resource?
pp. 60-60(1)
Authors: Freeman M.R.; Millett K.S.; Whitworth C.M.; Weitzman G.A.; Eblen A.C.; Hill G.A.

Reduction of high order multiple pregnancies by critically assessing blastocyst implantation potential
pp. 60-61(2)
Authors: Duke M.; Copperman A.; Grunfeld L.; Mukherjee T.; Sandler B.; Barritt J.

The importance of cytoplasmic halo formation in the evaluation of the pronucleus embryos (pn) to predict third day morphology and the pregnancy in ICSI cycles
pp. 61-61(1)
Authors: Zeyneloglu H.B.; Durak T.; Peker A.; Oktem M.; Acar M.; Bagis T.

Day 2 embryo transfer improves IVF-ET outcome in the poor responder
pp. 61-61(1)
Authors: Frankfurter D.; Keefe D.L.; Trimarchi J.B.

Understanding the emotional context for patients considering Multifetal Pregnancy Reduction (MFPR): conflicts and resolutions based upon the intensity of ''Medical,'' ''Moral,'' and ''Lifestyle'' frames
pp. 61-62(2)
Authors: Britt D.W.; Evans W.J.; Evans M.I.

Matched pair analysis of IVF versus ICSI for sibling oocytes
pp. 62-62(1)
Authors: Miles L.J.; Jackson K.V.; Pan Y.; Nureddin A.; Racowsky C.

Pregnancy following oocyte cryopreservation combined with preimplantation genetic diagnosis (PGD) of the embryos. A case report
pp. 62-62(1)
Authors: Miller K.A.; Ross S.; Levy B.; Graubert M.D.; Drews M.R.; Scott R.T.

Randomized comparison of murine blastocyst cryopreservation methods
pp. 63-63(1)
Authors: Walker D.L.; Hammitt D.G.; Session D.R.; Tummon I.S.; Dumesic D.A.; Thornhill A.R.

Clinical efficiency of vitrification on blastocysts transfer cycles
pp. 63-63(1)
Authors: Osada H.; Aono F.; Kuwayama M.; Morita H.; Teramoto S.; Kato O.

Ovarian tissue cryopreservation prior to chemotherapy in patients with Hodgkin's disease: Is it justified?
pp. 63-63(1)
Authors: Azem F.; Tanya C.; Dalit B.-Y.; Ami A.; Lessing J.B.; Goor O.

A prospective comparison of tamoxifen alone and tamoxifen-FSH combined protocol for IVF and fertility preservation in breast cancer patients
pp. 63-64(2)
Authors: Oktay K.H.; Buyuk E.; Davis O.K.; Veeck L.; Rosenwaks Z.

Developing mouse embryos progressively eliminate microinjected trehalose
pp. 64-64(1)
Authors: Eroglu A.; Elliott G.; Bhowmick P.; Wright D.; Toner M.; Toth T.L.

Vitrification of human mature oocytes in a straw to prevent the risk of liquid nitrogen contamination during storage
pp. 64-65(2)
Authors: Park S.E.; Kim T.J.; Hong S.W.; Chung H.M.; Yoon T.K.; Cha K.Y.

Acceptability of ovarian tissue donation at the time of organ donation
pp. 65-65(1)
Authors: Huang I.; Emery B.R.; Mizukami A.; Hatasaka H.H.; Carrell D.T.; Peterson C.M.

Laser-assisted hatching in combination of degenerated blastomere resection confers to higher implantation and pregnancy rates in frozen-thawed embryo transfer cycles
pp. 65-66(2)
Authors: Elliott T.A.; Taylor T.; Jones A.E.; Wright G.W.; Kort H.I.; Nagy Z.P.

Use of a unique freezing technology to cryopreserve ovarian tissue
pp. 66-66(1)
Authors: Prien S.D.; Bramwell C.; Andrews L.; Penrose L.; Marroquin P.

Early cleavage of GnRH agonist versus GnRH antagonist derived embryos
pp. 66-66(1)
Authors: Rabinson J.; Girsh E.; Pinchasov M.; Meltzer S.; Bar-Hava I.; Tur-Kaspa I.

Estrogen supplementation during GIFT treatment: A prospective randomized study
pp. 66-66(1)
Authors: Siebert T.I.; Decker A.D.; Kruger T.F.; Merwe J.P.V.d.

Vaginal versus intramuscular progesterone for luteal phase support in assisted reproductive technology: A systematic review with meta-analysis
pp. 66-67(2)
Authors: Olivier F.L.; Sanchez-Ramos L.; Kaunitz A.; Fox M.D.

Pre-treatment with oral contraceptive pill affects adversely implantation rate in IVF/ICSI cycles stimulated with rec-FSH and GnRH antagonists
pp. 67-67(1)
Authors: Kolibianakis E.M.; Albano C.; Tournaye H.; Camus M.; Van Steirteghem A.; Devroey P.

Evaluation of the added value of rec-hLH (Luveris(R)) in LH deficient undergoing ART
pp. 67-68(2)
Authors: Hassoud C.; Damon V.B.; Hadj S.; Salle B.

Recombinant luteinizing hormone ''Add-Back'' in normogonadotropic women treated with recombinant follicle stimulating hormone and cetrorelix acetate: a randomized, prospective trial
pp. 68-68(1)
Authors: Schoolcraft W.B.; Sauer M.V.; Frishman G.

Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonists administration: a randomized controlled trial
pp. 68-68(1)
Authors: Aboulghar M.A.; Mansour R.T.; Serour G.I.; Al-Inany H.G.; Amin Y.; Abou-Setta A.M.

The old is still beautiful: a meta-analysis of recombinant FSH versus human menopausal gonadotrophins
pp. 69-69(1)
Author: Al-Inany H.G.

Evaluation of mixed protocols with Bravelle (hFSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE): a comparison of patients 18-33 years and 34-40 years undergoing in vitro fertilization
pp. 69-69(1)
Authors: Rodriguez A.J.; Lifchez A.S.; Witt B.R.; Scholl G.M.; Karande V.C.; Marshall D.C.

A prospective randomized and blinded comparison between urinary and recombinant HCG for oocyte maturation in IVF cycles
pp. 69-70(2)
Authors: Abdelmassih V.; Oliveira F.G.; Goncalves S.P.; Varella A.D.; Diamond M.P.; Abdelmassih R.

Multiple birth family outcomes
pp. 70-70(1)
Authors: Ellison M.A.; Hotamisligil S.; Lee H.; Rich-Edwards J.W.; Pang S.C.; Hall J.E.

High dose of rec-LH overcomes the deleterious effect of high dose GnRH antagonist on embryonic implantation
pp. 70-70(1)
Authors: Escudero E.; Bennink H.J.T.C.; Boerrigter P.J.; Bunchoten H.; Pellicer A.; Simon C.

Coasting compares favorably to cryopreservation of all embryos for management of high responders
pp. 71-71(1)
Authors: Gibson H.E.; Jackson K.V.; Fox J.H.; Racowsky C.; Ginsburg E.S.

Using 100% embryo implantation IVF cycles to identify preferred embryo development patterns-morphokinetics
pp. 71-71(1)
Authors: Frankfurter D.; Hackett R.; Keefe D.L.; Trimarchi J.B.

Cost analysis for ART using a model of the effect of age and FSH levels upon pregnancy rates: the concept of a minimally acceptable pregnancy rate
pp. 71-72(2)
Authors: Neithardt A.B.; Catherino W.H.; Murdock C.M.; Segars J.H.

Beckwith-Wiedemann Syndrome and assisted reproductive technology
pp. 72-72(1)
Authors: Chang A.S.; Feinberg A.P.; Moley K.H.; DeBaun M.R.

A multi-center randomized controlled trial of expectant management vs. in vitro fertilization (Emvi) in women with fallopian tube patency
pp. 72-73(2)
Authors: Hughes E.G.; Beecroft M.L.; Claman P.; Tummon I.; Greenblatt E.; Fluker M.

Case report: evidences of parthenogenetic origin of ovarian teratoma
pp. 73-73(1)
Authors: Oliveira F.G.; Abdelmassih S.; Fracasso A.; Dozortzev D.; Nagy Z.P.; Abdelmassih R.

Magnetic resonanse imaging evaluation of adenomyosis with in IVF patients' pregnancy rate is linked to measures of junction zone
pp. 73-74(2)
Authors: Piver P.; Maubon A.; Kapella M.; Gana J.; Paulhiac S.; Aubard Y.

Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors: a preliminary report
pp. 74-74(1)
Authors: Fasouliotis S.J.; Davis O.; Schattman G.; Spandorfer S.D.; Kligman I.; Rosenwaks Z.

The risk of monozygotic twinning in an in vitro fertilization cycle (IVF) may be intrisinically related to oocyte quality
pp. 74-74(1)
Authors: Miller K.A.; Elkind-Hirsch K.E.; Bauman B.; Bergh P.A.; Scott R.T.

Congenital malformations and sex ratio in 1,303 infants born after IVF and ICSI (1995-2001)
pp. 74-75(2)
Author: Xiaoyan L.

Monozygotic twinning: a significant risk when performing blastocyst transfer as compared to day three embryo transfer
pp. 75-76(2)
Authors: Spandorfer S.D.; Veeck L.; Roberts J.E.; Davis O.K.; Rosenwaks Z.

Risk reduction for the type of glove used in ART procedures
pp. 75-75(1)
Authors: Quinn P.; Warneke D.

The ART pandemic of multiple pregnancies. Multiple births but not multiple pregnancies is a disease of age
pp. 76-76(1)
Authors: Werland H.; Madden J.; Guerami A.; Rodriguez A.; Barnett B.; Meintjes M.

Efficacy and safety of testosterone patches for the treatment of low sexual desire in surgically menopausal women
pp. 76-76(1)
Authors: Davis S.; Rees M.; Ribot C.; Moufarege A.; Rodenberg C.; Purdie D.

The effect of recombinant human luteinizing hormone on oocyte/embryo quality and treatment outcome in down-regulated women undergoing in vitro fertilization
pp. 76-77(2)
Authors: Perin P.M.; Maluf M.; Czeresnia C.E.; Sousa P.D.

Detection of alternatively spliced transcripts of human leukocyte antigen-g in single human preimplantation blastocysts using nested RT-PCR
pp. 77-77(1)
Authors: Yao Y.Q.; Barlow D.H.; Sargent I.L.

Blastomere transplantation in early human embryos
pp. 77-78(2)
Authors: Gleicher N.; Tang Y.

Ability of three-dimensional (3D) engineered endometrial tissue to support mouse gastrulation in vitro
pp. 78-78(1)
Authors: Liu H.-C.; He Z.; Chen C.-L.; Rosenwaks Z.

Inhibition of the vascular endothelial cell specific adhesion molecule VE-cadherin blocks gonadotropin-dependent folliculogenesis and corpus luteum formation
pp. 78-79(2)
Authors: Nakhuda G.S.; Pauli S.A.; Liao F.; Bohlen P.; Sauer M.V.; Zimmermann R.C.

In vitro growth of mouse primary and early preantral follicles in a 3-dimensional culture system
pp. 79-79(1)
Authors: Buyuk E.; Oktem O.; Roberts J.; Rosenwaks Z.; Oktay K.

Interference with survivin gene function in mouse embryos: Towards a molecular model for human embryo fragmentation
pp. 79-79(1)
Authors: Malter H.E.; Steuerwald N.; Cohen J.

Identification of ESTs of genes and a new gene related to compaction in preimplantation embryos of mouse
pp. 79-80(2)
Authors: Wen L.; Guangxiu L.

Fusion of human gametes requires a CD9 dependent clustering of a6b1 integrin-CD151 complexes on the oocyte membrane
pp. 80-80(1)
Authors: Wolf J.-P.; Monier-Gavelle F.; Rubinstein E.; Barraud V.; Bomsel M.; Boucheix C.

DNA methylation patterns in mouse and human zygotes
pp. 80-80(1)
Authors: Xu Y.; Krey L.; Grifo J.; Zhang J.

Reproductive outcomes in patients with recurrent pregnancy loss associated with a structural chromosome abnormality
pp. 80-81(2)
Authors: Sierra S.; Langlois S.; Stephenson M.D.

Pentraxin-3 gene expression in cumulus cells may be a molecular marker for egg quality
pp. 81-81(1)
Authors: Zhang X.J.; Moyse J.; Jarari N.; Confino E.; Kazer R.

Assisted artificial activation of electrical stimulation on human mature oocytes at different ages
pp. 81-82(2)
Authors: Shu Y.; Zhuang G.; Zhou C.; Zhang M.; Peng W.

Does laparoscopic excision of ovarian cysts significantly affect ovarian reserve? insights from in vitro fertilization cycles
pp. 82-82(1)
Authors: Somigliana E.; Ragni G.; Benedetti F.; Vegetti W.; Borroni R.; Crosignani P.

Recurrence of hydrosalpinges after cuff neosalpingostomy in a poor prognosis population
pp. 82-82(1)
Authors: Bayrak A.; Harp D.; Saadat P.; Mor E.; Paulson R.J.

1,000 office hysteroscopies for infertility: feasibility and findings
pp. 82-83(2)
Authors: Hinckley M.D.; Milki A.A.

Tubal cornual anastamosis following failed tubal canalization
pp. 83-83(1)
Authors: Graham J.A.; Awartani K.; McComb P.

Hysteroscopic evaluation for chronic genital spotting in patients with past abortion history and without sonographic abnormality
pp. 83-83(1)
Author: Oh S.-T.

A curriculum and performance assessment tool for saline sonohysterography
pp. 83-84(2)
Authors: Luterzo J.; Parker J.; Armstrong A.; Alvero R.

Assisted reproductive nursing: an emerging specialty
pp. 84-84(1)
Authors: Mitchell A.M.; Wagner C.; Mittelstaedt M.E.

Multi-center patient survey on injection pain of recombinant gonadotropin products administered for controlled ovarian stimulation (COS)
pp. 84-84(1)
Authors: Keene P.; Lesser C.; Morrissey D.

Immediate post-transfer voiding does not affect pregnancy rates
pp. 85-85(1)
Authors: Russell E.; Acosta M.; Grunfeld S.; Beer K.; Graziano J.; Mukherjee T.

Follicle number after 5 days of stimulation as a predictor of oocyte yield for in vitro fertilization
pp. 85-85(1)
Authors: Hammond K.R.; Dharia S.P.; Steinkampf M.P.

Is there a true difference in the amount of drug delivered using different brands of 1 ml syringes versus the pen-injector device?
pp. 85-86(2)
Authors: Benson S.; Hamilton G.S.; Gysler M.

Patient satisfaction with the communication process used to inform them of the results of their first assisted reproductive technology cycle
pp. 86-86(1)
Authors: Wagner C.; Groh C.

Assessing possible wastage associated with commonly used syringes for drug administration in controlled ovarian stimulation
pp. 86-86(1)
Authors: Benson S.; Hamilton G.S.; Gysler M.

''Everything came with a price:'' women's decision-making regarding multifetal pregnancy reduction
pp. 86-87(2)
Author: Collopy K.S.

Assessment of attitudes regarding directives of oocytes among ovum donors in an egg donation program
pp. 87-87(1)
Authors: Adsuar N.; Pritts E.; Olive D.L.; Lindheim S.R.

Decline of serum beta-hCG and spontaneous abortion: defining the normal curve
pp. 87-88(2)
Authors: Chung K.; Barnhart K.; Sammel M.D.; Zhou L.; Guo W.; Hummel A.

High pretreatment folic acid level increases treatment failure of methorexate in ectopic pregnancy
pp. 88-88(1)
Authors: Rodriguez L.I.; Takacs P.; Pietro P.; Kang J.

Trophoblast inclusions are rare in elective terminations and normal deliveries, but common in cases with karyotypic abnormalities
pp. 88-88(1)
Authors: Kliman H.J.; McSweet J.C.; Franco A.; Ying X.; Zhao Y.; Stetten G.

Pregnancy after fibroid uterine artery embolization-results from the Ontario Uterine Fibroid Embolization Trial
pp. 88-89(2)
Authors: Pron G.; Mocarski E.; Vilos G.; Bennett J.; Common A.; Vanderburgh L.

Advancing age is associated with increased AUC (area under the curve) for E2 (estradiol) production per mature follicle and decreased AUC per FSH stimulation irrespective to the protocol of ovarian stimulation
pp. 89-89(1)
Authors: Mitwally M.F.M.; Crickard K.; Sullivan M.; Batt R.E.; Yeh J.; Casper R.F.

On the search for the genetic background of the primary idiopathic infertility: the leukemia-inhibitory factor gene mutations in the population of infertile women
pp. 89-90(2)
Authors: Beranova M.; Sima P.; Rokyta Z.; Ulcova-Gallova Z.; Vanecek T.; Sima R.

Causes of infertility and ovarian cancer risk
pp. 90-90(1)
Authors: Brinton L.A.; Lamb E.J.; Moghissi K.S.; Scoccia H.; Westhoff C.; Althuis M.

Ovarian function in pediatric brain cancer survivors after laparoscopic oophoropexy
pp. 90-90(1)
Authors: Kuohung W.; Laufer M.R.; Marcus K.J.; Cheng D.M.; Diller L.R.

Serum Mullerian inhibiting substance levels in adolescents with anovulatory cycles and normally menstruating girls
pp. 90-91(2)
Authors: Kives S.; Siow Y.; Perlman S.; Hertweck P.; Fallat M.E.

Inhibition of nitric oxide production by N-Nitro-L-arginine methyl ester increased the expression of type I collagen in human peritoneal fibroblasts
pp. 91-91(1)
Authors: Saed G.M.; Abu-Soud H.M.; Diamond M.P.

Limitations of cryopreserved sperm for ICSI in men with nonobstructive azoospermia
pp. 91-91(1)
Authors: Hopps C.V.; Veeck L.L.; Takeuchi T.; Palermo G.D.; Rosenwaks Z.; Schlegel P.N.

Synaptonemal complex defects in a man with nonobstructive azoospermia
pp. 91-92(2)
Authors: Martin R.H.; Sun F.; Kozak G.; Trpkov K.; Greene C.; Ko E.

Towards a sutureless vasovasostomy: use of biomaterials and surgical sealants in a rodent vasovasostomy model
pp. 92-92(1)
Authors: Schiff J.D.; Li P.S.; Goldstein M.

Back-up frozen semen sample use in men planning on giving fresh semen samples for in vitro fertilization (IVF)
pp. 92-92(1)
Authors: Russell S.T.; Nehra A.X.; Session D.R.; Walker D.L.; Thornhill A.R.

Significance of serum follicle-stimulating hormone levels for evaluating improvement in spermatogenesis following varicocele repair
pp. 92-93(2)
Authors: Pasqualotto F.F.; Lucon A.M.; de Goes P.M.; Pasqualotto E.B.; Sobreiro B.P.; Arap S.

Do pathologists accurately read testis biopsies with mixed histologic patterns in the ICSI era?
pp. 93-93(1)
Authors: Cooperberg M.R.; Jad A.; Cha I.; Turek P.J.

Histomorphometric and cytogenetic study of human testicular aging
pp. 93-93(1)
Authors: Dakouane M.; Bicchieray L.; Bergere M.; Albert M.; Vialard F.; Selva J.

Vasectomy reversal. cost and service differences between academic institutions and private practices
pp. 93-94(2)
Authors: Ahn H.; Land S.

Is day 3 embryo quality indicative of day 5 blastocyst development? comparison of clinician vs. computer selection
pp. 94-94(1)
Authors: Neuber E.; Mahutte N.; Arici A.; Sakkas D.

Preliminary results of a prospective randomized study to assess the value of laser assisted hatching before cleavage stage embryo transfer among good-prognosis in vitro Fertilization (IVF) patients
pp. 94-94(1)
Authors: Carter J.; Graham J.; Han T.; Davis A.; Richter K.S.; Widra E.

Ovarian function after autotransplantation of frozen-thawed human ovarian tissue: an experience of human ovarian grafting into two heterotopic sites
pp. 94-95(2)
Authors: Kim S.S.; Hwang I.-T.; Lee H.-C.; Kim D.H.

Electro-acupuncture for ovum pick-up-a good alternative to conventional anesthetics
pp. 95-95(1)
Authors: Humaidan P.S.; Bungum L.; Andersen K.B.

Pre-embryo transfer sham at the time of embryo transfer improves clinical pregnancy rates
pp. 95-95(1)
Authors: Neithardt A.B.; Murdock C.M.; Segars J.H.; McKeeby J.L.

The role of patient age when deciding to transfer at the blastocyst stage. should we be more aggressive with day 3 transfers in older patients?
pp. 95-96(2)
Authors: Hill K.; Barnett B.; Douglas J.; Rodriguez A.; Chantilis S.; Meintjes M.

Assessment of the predictive value of follicular fluid IL-6 in IVF cycles
pp. 96-96(1)
Authors: Bedaiwy M.A.; Falcone T.; Goldberg J.M.; Attaran M.; Miller K.; Agarwal A.

Optimizing stimulation protocols in IVF cycles using the GnRH antagonist
pp. 96-97(2)
Authors: Copperman A.B.; Sandler B.; Mukherjee T.; Grunfeld L.; Bergh P.; Scott R.T.

Serum anti mullerian hormone as a novel predictive factor of success in art among women with polycystic ovary syndrome?
pp. 97-97(1)
Authors: Hazout A.; Junca A.M.; Meur A.L.; Ternaux F.; Cohen-Barcie P.

Ejaculatory abstinence less than 3 days results in a higher pregnancy rate (PR) following intrauterine insemination (IUI)
pp. 97-98(2)
Authors: Jurema M.W.; Vieira A.D.D.; Bankowski B.; Zhao Y.; Wallach E.; Zacur H.

Offspring gender ratios differ between day 3 and day 5 embryo transfer
pp. 98-98(1)
Authors: McCaffrey C.; Berkeley A.; Grifo J.; Kump L.; Licciardi F.; Noyes N.

Post-processed semen specimens with deficits in strict morphology may not require intracytoplasmic sperm injection (ICSI) to achieve good reproductive outcomes
pp. 98-99(2)
Authors: Bar-Chama N.; Barritt J.; Duke M.; Miller K.; Scott R.; Copperman A.

The IVF poor responder: predicting a good outcome
pp. 99-99(1)
Authors: Ryley D.A.; Regan M.; Connolly C.; Harris D.; Timmreck L.S.; Reindollar R.H.

Day 5 blastocyst stage is directly proportional to pregnancy and implantation rates
pp. 99-99(1)
Authors: Langley M.T.; Marek D.E.; Nackley A.C.; Doody K.M.; Doody K.J.

Comparing data mining and logistic regression for predicting IVF outcome
pp. 100-100(1)
Authors: Trimarchi J.R.; Goodside J.; Passmore L.; Silberstein T.; Hamel L.; Gonzalez L.

Effect of pronuclear grade on blastulation rate
pp. 100-100(1)
Authors: Marek D.E.; Langley M.T.; Weiand L.A.; Nackley A.C.; Doody K.M.; Doody K.J.

Predictive value of the serum inhibin B level repeated at 2-day intervals during controlled ovarian hyperstimulation (COH)
pp. 100-101(2)
Authors: Roux-Demerle C.; Pigny P.; Leroy M.; Dewailly D.; Decanter C.

IVF, with a maximum of two embryo replacement, is the treatment of choice for high responding patients
pp. 101-101(1)
Authors: Grunfeld L.; Mukherjee T.; Sandler B.; Scott R.T.; Copperman A.B.

Women with intramural fibroids less than 5cm in diameter and not distorting the endometrial cavity have a significantly lower pregnancy rate at in vitro fertilization/intracytoplasmic sperm injection when compared to women without fibroids
pp. 101-101(1)
Authors: Ajayi R.A.; Arilesere A.I.; Igbineweka O.M.; Melie N.A.; Adeniyi O.A.

Impact of embryo selection on pregnancy rate following fresh embryo transfer
pp. 102-102(1)
Authors: Hinrichsen M.J.; Jackson K.V.; Dahncke W.; Ginsburg E.S.; Racowsky C.

Assisted hatching-a meta-analysis of randomized controlled trials
pp. 102-102(1)
Authors: Sallam H.N.; Sadek S.S.; Agameya A.-F.A.

Early cleavage assessment in embryos from Intracytoplasmic Sperm Injection (ICSI) cycles
pp. 103-103(1)
Authors: Guilherme P.; Rossi L.M.; Iaconelli A.; Rocha C.C.; Locambo C.V.; Borges E.

Sub-optimal fertilization: a new parameter to predict successful outcomes in assisted reproduction
pp. 103-103(1)
Authors: Iaconelli A.; Rossi L.M.; Guilherme P.; Rocha C.C.; Locambo C.; Borges E.

High endometrial aromatase P450 messenger RNA expression is associated with poor IVF outcome
pp. 103-104(2)
Authors: Brosens J.J.; European Fertility Association EFA

Transfer of embryos with even a single multinucleated blastomere significantly reduces pregnancy and implantation rates
pp. 104-104(1)
Authors: Duke M.; Basile N.; Johnson M.; Copperman A.; Sandler B.; Barritt J.

Alternate day triptorelin: a cost effective method for controlled ovarian hyperstimulation
pp. 104-104(1)
Authors: Karatekeli E.; Ozornek H.; Ergin E.; Ongun B.

A randomized prospective trial comparing GnRH antagonist/rFSH versus GnRH Agonist/rFSH in women pretreated with oral contraceptives prior to IVF
pp. 104-105(2)
Authors: Barmat L.I.; Chantilis S.J.; Hurst B.S.; Dickey R.P.

Does exogenous LH activity influence the outcome in IVF and not in ICSI cycles?
pp. 105-105(1)
Authors: Platteau P.; Smitz J.; Albano C.; Sorensen P.; Arce J.-C.; Devroey P.

Synchronization of the follicle cohort with GnRH antagonists prior to the start of gonadotropins-a novel stimulation protocol for IVF
pp. 105-106(2)
Authors: Doody K.J.; Langley M.T.; Marek D.E.; Nackley A.C.; Doody K.M.

Intrafollicular profiles of reproductive hormones in IVF treatment cycles employing GnRH antagonists and agonists
pp. 106-106(1)
Authors: Noyes N.; Yegorov V.; Katz J.; Levitz M.; Krey L.

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women following a low dose step-up protocol with weekly increments of 25 IU follitropin beta
pp. 106-107(2)
Author: Leader A.

Comparison of FSH flare in poor responders undergoing in vitro fertilization (IVF) with and without prior oral contraceptive suppression
pp. 107-107(1)
Authors: Keltz M.D.; Sharma P.; Stein D.E.

Comparison of three different protocols in the group of advanced maternal age with diminished ovarian reserve
pp. 107-108(2)
Authors: Karlikaya G.; Kahraman S.; Vanlioglu F.; Karagozoglu H.; Aygun M.; Kumbak B.

A randomized, controlled trial of low dose GnRH antagonist started on day 2 in ''poor responders'' undergoing stimulation with luteal phase GNRH agonist, estrogen priming and high-dose FSH
pp. 108-108(1)
Authors: Fisch J.D.; Sher G.; Keskintepe L.

Pre-treatment with oral contraceptive pill improves outcome in IVF cycles of poor-responders using the GNRH antagonist
pp. 108-108(1)
Authors: Copperman A.B.; Mukherjee T.; Sandler B.; Grunfeld L.; Bergh P.A.; Scott R.T.

Phosphorylation and nuclear translocation of SAPK/JNK and p38MAPK correlate negatively with mouse embryo development after culture
pp. 108-109(2)
Authors: Puscheck E.; Wang Y.; Wang F.; Lewis J.J.; Wygle D.; Rappolee D.

Outcome of first IVF/ICSI-cycle in couples who failed conceiving during intrauterine insemination
pp. 109-109(1)
Authors: Bungum L.J.; Bungum M.; Humaidan P.; Andersen C.Y.

Obstetrical and perinatal outcomes of ICSI versus natural singleton pregnancies
pp. 109-109(1)
Authors: Lin K.; Kang H.J.; Neri Q.V.; Rosenwaks Z.; Palermo G.D.

Does sperm quality affect reproductive outcome in recipients using a shared donor?
pp. 109-110(2)
Authors: Liotta D.; Hariprashad J.; Zaninovic N.; Veeck L.

Does cervical infection affect the results of IVF and ICSI? a meta-analysis of controlled studies
pp. 110-110(1)
Authors: Sallam H.N.A.; Sadek S.S.; Ezzeldin F.

Ovarian suppression with oral contraceptive pills prior to ART: can you get too much of a ''good'' thing?
pp. 110-110(1)
Authors: Parker J.D.; Leondires M.P.; Segars J.H.; McKeeby J.L.

Addition of metformin with gonadotropin stimulation in PCOS patients
pp. 110-111(2)
Authors: Chang A.S.; Odem R.R.; Ratts V.S.

Effect of metformin on subgroups of patients with polycystic ovaries undergoing controlled ovarian hyperstimulation for assisted reproductive techniques
pp. 111-111(1)
Authors: Vanlioglu F.; Kahraman S.; Karlikaya G.; Karagozoglu H.; Aygun M.

Does dehidroepiandrosterone sulfate (Dheas) co-treatment improve art outcome? A prospective, randomized, double-blind placebo-controlled trial
pp. 111-112(2)
Authors: Divita A.E.; Kanzepolsky L.S.; Notrica J.A.; Neuspiller F.D.; Fried E.P.d.

Bee venom treatment of refractory pregnancy. A modern trend
pp. 112-112(1)
Authors: Ali A.; Mostafa M.; Hamed W.; Mekled A.

Pregnancy outcome of IVF/ICSI with profound teratospermia (Kruger strict criteria of zero)
pp. 112-112(1)
Authors: McKenzie L.J.; Buster J.E.; Cisneros P.; Lamb D.; Lipshultz L.; Carson S.A.

Use of a novel technique for the conservative recovery of small quantities of cryopreserved nonrenewable sperm specimens for ICSI
pp. 112-113(2)
Authors: Ashby R.K.; Jackson K.V.; Retzloff M.G.; O'Leary T.F.; Racowsky C.

Vertical transmission, de novo, and expansion of Y chromosome microdeletion in male fetuses pregnant after intracytoplasmic sperm injection (ICSI)
pp. 113-113(1)
Authors: Kim H.A.; Lee S.H.; Cho S.W.; Han J.E.; Lee S.; Yoon T.K.

The sperm DNA integrity assay (SDI(TM)) a valuable method for assessing sperm vitality in preparation for in vitro fertilization (IVF)
pp. 113-113(1)
Authors: Ahlering P.; Keskintepe L.; Sher G.; Fisch J.D.; Danner L.; Maasarani G.

Sperm chromatin structure assay (SCSA(R)) parameters relationship with fertilization rate, blastocyst development and pregnancy outcomes following in vitro fertilization (IVF) and IVF with intracytoplasmic sperm injection (ICSI)
pp. 113-114(2)
Authors: Evenson D.P.; Larson-Cook K.L.; Virro M.

Sperm chromatin structure assay (SCSA) parameters provide additional prognostic information to conventional semen analysis for couples trying to conceive
pp. 114-114(1)
Authors: Larson-Cook K.L.; Brannian J.D.; Hansen K.A.; Bormann S.F.; Evenson D.P.

Spermatozoa aneuploidy for 15 chromosomes by fluorescence in situ hybridization (FISH) and somatic cell karyotypes from two hundred thirty oligoasthenoteratozoospermic (OAT) males
pp. 114-115(2)
Authors: Kearns W.G.; Richter K.S.; Pang M.-G.

Sperm cryopreservation for male patients with cancer: an epidemiological analysis
pp. 115-115(1)
Authors: Chung K.; Schafer D.; Knee G.; Efymow B.; Blasco L.; Patrizio P.

Motility of aspirated spermatazoa and impact upon intracytoplasmic sperm injection and in vitro fertilization outcomes
pp. 115-116(2)
Authors: Moghadam K.K.; Nett R.; Robins J.; Awadalla S.; Scheiber M.; Williams D.B.

Are ICSI patients compromised when comparing the pregnancy and cryopreservation outcomes with those patients with IVF? A study of more than 3,300 treatment cycles
pp. 116-116(1)
Authors: Perez O.; Chantilis S.; Douglas J.; Rodriguez A.; Madden J.; Meintjes M.

Analysis of gene expression profiles in preimplantation stage embryos by DNA microarrays
pp. 116-116(1)
Authors: Wang S.; Cowan C.; Harris D.; Witmyer J.; Melton D.; Powers D.

Is reduced blastocyst development associated with chromosomal abnormality after PGD?
pp. 117-117(1)
Authors: Ye Z.; Park J.; Zaninovic N.; Xu K.P.; Veeck L.L.; Rosenwaks Z.

The impact of media pH on the development of human embryos
pp. 117-117(1)
Authors: Khabani A.; Scott L.; Tufts K.; Craig L.; Soules M.; Kan M.

Aneuploidy rates in unfertilized oocytes, from fertile anonymous donors versus those found in young infertile patients
pp. 117-118(2)
Authors: Thorsell L.P.; Oliver J.

Pronuclear Scoring: correlation with Chromosome Complement
pp. 118-118(1)
Authors: Thorsell L.P.; Oliver J.; Geltinger M.; Klein L.; Harton G.; Stern H.

Whole genome amplification/hybridization following ooplasmic aspiration reveals no evidence of genomic DNA disturbance
pp. 118-118(1)
Authors: Malter H.E.; Wells D.; Bermudez M.G.; Cohen J.

Fertilization characteristics of oocytes with incomplete maturation in vivo
pp. 118-119(2)
Authors: Sterbutzel P.; Takeuchi T.; Neri Q.V.; Wang A.; Rosenwaks Z.; Palermo G.D.

Pre-implantation genetic diagnosis (PGD) for aneuploidy does not significantly improve chances for conception in an at risk population undergoing IVF
pp. 119-119(1)
Authors: Schattman G.L.; Xu K.P.; Spandorfer S.; Navarro-Pando J.; Rosenwaks Z.

Effect of karyotype and cell number on blastocyst development following day 3 biopsy
pp. 119-119(1)
Authors: Stevens J.M.; Schoolcraft W.B.; Rawlins M.; Gardner D.K.; Munne S.

Fertilization, embryo development, and chromosomal status after intracytoplasmic sperm injection of metaphase I human oocytes
pp. 119-120(2)
Authors: Jones A.E.; Taylor T.; Wright G.W.; Kort H.I.; Massey J.B.; Nagy Z.P.

The relationship of color and power doppler ultrasound parameters of pulsatility and resistance indices and sub-endometrial blood flow with endometrial thickness on day of oocyte retrieval and their relationship to clinical pregnancy rate
pp. 121-121(1)
Authors: Dietterich C.; Check J.H.; Lurie D.; Choe J.K.; Krotec J.W.

Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of rapid ICSI-ZIFT in patients with endometriosis
pp. 121-121(1)
Authors: Sahebkashaf H.; Aleyassin A.; Saidi H.; Ghalavand N.; Adel H.G.; Sahebkashaf H.

Affect of low intensity light on mice embryo development using the time laps ''EmbryoGuard'' system
pp. 121-122(2)
Authors: Yavin S.; Aroyo A.; Arav A.

IUI in women 38 and 39 years old
pp. 122-122(1)
Authors: Wainer R.; Ayel J.P.; Albert M.; Khetsuriani T.; Bergere M.; Selva J.

A prospective, randomized study of ultrasound-guided embryo transfer
pp. 122-122(1)
Authors: Weissman A.; Farhi J.; Steinfeld Z.; Mutsafi R.; Nahum H.; Levran D.

Clinical outcome and efficacy of half-ICSI treatments in non-male factor infertility
pp. 122-123(2)
Authors: Min D.M.; Song S.J.; Lim C.K.; Byun H.K.; Koong M.K.; Jun J.H.

Effectiveness of the modified natural cycle ICSI: results of a pilot study
pp. 123-123(1)
Authors: Vogel N.E.A.; Pelinck M.-J.; Arts E.G.J.M.; Hoek A.; Simons A.H.M.; Heineman M.J.

The relationship of color and power doppler ultrasound parameters of pulsatility and resistance indices and sub-endometrial blood flow with endometrial thickness on day prior to progesterone administration and their relationship to clinical pregnancy rate following frozen embryo transfer
pp. 123-123(1)
Authors: Check J.H.; Dietterich C.; Lurie D.; Choe J.K.; Nazari A.

The effect of growth hormone on the development of in vitro matured unstimulated human oocytes
pp. 123-124(2)
Authors: Sophonsritsuk A.; Suwajanakorn S.; Pruksananonda K.; Sereepapong W.; Ahnonkitpanit V.; Virutamasen P.

Intracytoplasmic sperm injection: optical magnification during sperm selection and microinjection affects fertilization, cleavage, and pregnancy rates
pp. 124-124(1)
Authors: Esteves S.C.; Guidi A.R.; Zabaglia S.F.C.; Verza S.

Embryo transfer quality and provider-specific pregnancy rates in IVF-ET
pp. 124-125(2)
Authors: Eisermann J.; Bustillo M.; Thompson K.; Wood E.; Riley E.; La J.; Palme J.; Collazo I.

Ultrasound and hysteroscopic findings in women with a history of difficult embryo transfers
pp. 125-125(1)
Authors: Marikinti K.; Mathews T.; Ball J.; Brinsden P.

Oocyte recovery and maturity following ovulatory doses of ovidrel
pp. 125-125(1)
Authors: Carson R.; McShane P.; Pang S.; Glatstein I.

Fertility preservation using ART and embryo cryopreservation prior to chemotherapy in breast cancer patients. New and safe protocol for ovarian stimulation
pp. 125-126(2)
Authors: Meirow D.; Maman E.; Farber B.; Kaufman B.; Dor J.

The impact of assisted reproduction in the definition and incidence of unexplained infertility
pp. 126-126(1)
Authors: Ruiz A.; De los Santos M.J.; Vidal C.; Remohi J.; Pellicer A.

Efficacy of day 4 embryo transfer (ET) in minimizing weekend staffing requirements
pp. 126-126(1)
Authors: Kiltz R.J.; Woodhouse D.J.; Miller D.B.; Sciera A.M.; Corona J.T.

Timing blastocyst transfer: Targeting the implantation window
pp. 126-126(1)
Authors: Ruhlmann C.; Martinez A.G.; Terrado G.; Rolla E.D.; Cattaneo A.R.; Nicholson R.E.

Egg collection with a double lumen needle in poor responder patients undergoing in vitro fertilization treatment
pp. 127-127(1)
Authors: Ellenbogen A.; Michaeli M.; Ballas S.

Reduced incidence of embryo retention in the transfer catheter after universal adaptation of mid-cavity transfer by a large multiple clinician IVF center
pp. 127-127(1)
Authors: Silberstein T.; Trimarchi J.R.; Frankfurter D.; Pagidas K.; Keefe D.; Plosker S.

Does a difficult embryo transfer affect the results of IVF and ICSI? A meta-analysis of controlled studies
pp. 127-127(1)
Authors: Sallam H.N.A.; Sadek S.S.; Agameya A.-F.A.

Fragment removal in day 3 human embryos in routine IVF
pp. 127-127(1)
Authors: Amorocho B.; Gomez E.; Perez-Cano I.; Landeras J.; Nicolas M.; Ballesteros A.

Ultrasound-guided embryo transfer: Does it improve IVF success?
pp. 127-128(2)
Authors: Shamonki M.I.; Spandorfer S.D.; Roberts J.E.; Rosenwaks Z.

Comparison of recovery and viability of sperm in ICSI pipette after ultra rapid freezing or slow freezing
pp. 128-128(1)
Authors: Sohn J.O.; Jun S.H.; Park L.S.; Kim E.K.; Chung T.G.; Lee D.R.

Trans-abdominal follicular aspiration for oocyte retrieval in patients with abnormal pelvic anatomy
pp. 128-128(1)
Authors: Gargiulo A.R.; Ginsburg E.S.; Politch J.A.; Benson C.B.

Semen sample collection in medium has no beneficial effect on fertilization and pregnancy rates
pp. 128-129(2)
Authors: Isiklar A.; Mercan R.; Balaban B.; Mumcu A.; Alatas C.; Urman B.

Comparison of all plastic syringe (Henke-Sass) and glass syringe (Hamilton) for embryo transfer
pp. 129-129(1)
Authors: Mahadevan M.; Moutos D.; Maris M.; Miller M.

Endocervical lavage technique for embryo transfer improves pregnancy outcome in assisted reproductive techniques
pp. 129-130(2)
Authors: Allahbadia G.N.; Gandhi G.N.; Kaur K.; Malik S.; Mugloo J.; Merchant R.

Prospective randomized comparison of an ultrasound-guided embryo transfer versus a blind catheter placement
pp. 130-130(1)
Authors: Marconi G.; Young E.; Vilela M.; Bello A.; Young E.; Sueldo C.

Uterine position at real embryo transfer compared to mock embryo transfer
pp. 130-130(1)
Authors: Henne M.B.; Jun S.; Milki A.A.

Hyperbaric oxygen therapy and in vitro fertilization-a pilot study
pp. 130-131(2)
Authors: Voorhis B.J.V.; Greensmith J.E.; Dokras A.; Maifeld M.R.; Sparks A.E.T.; Syrop C.H.

Intramuscular versus vaginal progesterone in assisted reproduction
pp. 131-131(1)
Author: Porcu E.

Motility of the endometrium after acupuncture treatment
pp. 131-131(1)
Authors: Paulus W.E.; Zhang M.; Strehler E.; Sterzik K.

The use of transdermal heat to relieve pain post-oocyte retrieval
pp. 131-131(1)
Authors: Robb P.A.; Robins J.C.; Petty S.; Thomas M.A.

The effect of hydrosalpinx on IVF outcome: a prospective, randomised controlled trial of vaginal ultrasound-guided hydrosalpinx aspiration during egg collection
pp. 131-132(2)
Authors: Hammadieh N.; Afnan M.; Sharif K.; Evans J.; Amso N.

The value of genetic counseling evaluation of egg donors
pp. 132-132(1)
Authors: Fordham K.; Ramsey D.; Bhatt S.

Relationship of follicular fluid growth factors with IVF outcome
pp. 132-132(1)
Authors: Bedaiwy M.; Said T.M.; Agarwal A.; Pasqualotto E.

Fertilization outcome of Metaphase I oocytes following intra-cytoplasmic sperm injection
pp. 132-133(2)
Authors: Huang I.; Chacon R.R.; Sahekian V.; Standing L.; Jordan B.; Khorram O.

The prognosis for patients with a cancelled IVF cycle
pp. 133-133(1)
Authors: Fruhman G.; Krey L.; Licciardi F.

Does smoking cessation normalize ovarian response in women undergoing in vitro fertilization?
pp. 133-133(1)
Authors: Hammond K.R.; Dharia S.P.; Steinkampf M.P.

Post-wash sperm motility as a predictor of in vitro fertilization rate in patients without a diagnosis of male infertility
pp. 133-134(2)
Authors: Chang W.Y.J.; DeCherney A.H.; Surrey M.W.; Hill D.L.

The effect of a drop in serum E2 levels during controlled ovarian stimulation and oocyte/embryo quality in donors
pp. 134-134(1)
Authors: Cobo A.; Troncoso C.; Bosch E.; Santos M.J.d.l.; Pellicer A.; Remohi J.

Human immunodeficiency virus positive women treated with in vitro fertilization
pp. 134-134(1)
Authors: Miller N.R.; Santoro N.

Intra muscular versus intra vaginal progesterone as luteal phase and early pregnancy support in patients undergoing IVF-ET
pp. 134-135(2)
Author: Sofat S.S.S.

Gestational surrogacy enhances implantation rates in egg donation cycles
pp. 135-135(1)
Authors: Adams C.A.; Anderson L.S.; Scroop A.L.; Wood S.H.

Quality of SART-affiliated infertility clinic websites: evaluation based on the American Medical Association Guidelines
pp. 135-135(1)
Authors: Huang J.Y.J.; Discepola F.; Al-Fozan H.; Tulandi T.

In vitro fertilization versus COH/IUI as first line treatment for unexplained infertility in women under 35: a cost-based decision analysis
pp. 135-136(2)
Authors: Kalra S.K.; Milad M.P.; Grobman W.A.

Comparison of IVF-ET outcome before and after introduction of an embryo ICU system
pp. 136-136(1)
Authors: Yoshida A.; Tanaka M.; Suzuki H.; Takahashi A.; Seida K.; Fujimori T.

The utilization of genetic counseling in assisted reproductive technology (ART) clinics
pp. 136-136(1)
Authors: Fordham K.; Schlenker E.; Peters K.; Bhatt S.

The effect of seasonal changes on IVF outcome
pp. 136-137(2)
Authors: Ferber-Meiri B.; Lamer-Geva L.; Levron J.; Shulman A.; Bider D.; Levin T.

Reduction of high order multiples without affecting pregnancy
pp. 137-137(1)
Authors: Anderson A.R.; Weikert M.L.; Crain J.L.

Quality of life (QOL) differentiation analysis in patients undergoing controlled ovarian stimulation (COS) with two different preparations of recombinant human follicle-stimulating hormone (r-hFSH)
pp. 137-137(1)
Authors: Daya S.; Wikland M.; Silverberg K.M.; Blatz S.; Duru G.; Beresniak A.

AUC (Area Under The Curve) for E2 (Estradiol) levels do not reflect E2 levels on the day of hCG administration among individual patients undergoing COH (Controlled Ovarian Hyperstimulation) for IVF-ET (In-Vitro Fertilization and Embryo Transfer)
pp. 137-138(2)
Authors: Mitwally M.F.M.; Bhakoo H.S.; Crickard K.; Sullivan M.W.; Batt R.E.; Yeh J.

Does intracytoplasmic sperm injection in women aged forty years and older improve fertilization and pregnancy rates?
pp. 138-138(1)
Authors: Kuohung W.; Racowsky C.

The value of genetic screening of oocyte donor couples
pp. 138-138(1)
Authors: Tavares R.L.C.; Aguiar R.A.L.; Aguiar M.B.P.; Lemos C.N.C.; Camargos M.G.R.; Camargos A.F.

Frank discussions of longevity are important prior to addressing the fertility needs of HIV-1 seropositive patients
pp. 138-139(2)
Authors: Pena J.E.; Chu M.; Thornton M.H.; Sauer M.V.

Weekend blastocyst transfers. Are patients compromised?
pp. 139-139(1)
Authors: Ward D.; Bookout D.; Chantilis S.; Guerami A.; Madden J.; Meintjes M.

Spontaneous intrauterine pregnancy in a woman with both Kartagener's syndrome and polycystic ovarian disease-a case report
pp. 139-139(1)
Authors: Jain S.; Kotarba D.; Leader A.

HIP embryos: effective criteria for high pregnancy rates with low high order multiples
pp. 139-140(2)
Authors: Witmyer J.; Wang S.; Alper M.; Powers R.D.

A Markov model of the cost effectiveness of a new highly-purified, human-derived FSH versus follitropin- using comparative clinical trial data
pp. 140-140(1)
Authors: Hatoum H.T.; Keye W.R.; Marrs R.P.; Walton S.M.; Marshall D.C.

An oocyte donor's willingness to donate-does the recipient's lifestyle make a difference?
pp. 140-140(1)
Authors: Kump L.; Licciardi F.; Krey L.; Noyes N.; Grifo J.; Berkeley A.S.

A retrospective analysis comparing outcomes data: Ovidrel 250mcg versus u-hCG in GnRH-agonist down regulated ART patients
pp. 140-141(2)
Authors: DeVane G.W.; Jaffe S.B.; Loy R.A.; Gangrade B.K.; Sgarlato L.

The comparison of pregnancy outcomes of progesterone or progesterone+estradiol for luteal phase support in ICSI-ET cycles
pp. 141-141(1)
Authors: Gorkemli H.; Aktan M.; Ak D.; Duman S.; Acyurek C.

Does cryopreservation of embryos in patients at risk for ovarian hyperstimulation syndrome lower the odds of a successful pregnancy?
pp. 141-141(1)
Authors: Graziano V.; Check J.H.; Wilson C.; Choe J.K.; Swenson K.

Successful production of blastocysts following ultrarapid vitrification of germinal vesicle oocytes in mice by step-wise equilibrium
pp. 141-142(2)
Authors: Aono N.; Yoshida H.; Abe Y.; Hara K.; Sasada H.; Sato E.

Successful sterile vitrification of human zygotes and blastocysts
pp. 142-142(1)
Authors: Hata K.; Kuwayama M.; Teramoto S.; Kato O.

Can vitrifaction on cryoloops be used effectively for cryopreservation of day 3 cleavage stage embryos?
pp. 142-142(1)
Authors: Desai N.; Blackmon H.; Goldfarb J.

Pregnancy after vitrification of human oocytes and blastocysts using same cryoprotectant solution, ethylene glycol, and sucrose
pp. 143-143(1)
Authors: Kim T.J.; Hong S.W.; Park S.E.; Cha K.Y.

Effect of vitrification procedure on the developmental capacity of the mouse embryos undergone microsurgical manipulation
pp. 143-143(1)
Authors: Lee D.R.; Yang Y.H.; Chung H.M.; Kim T.; Cho J.H.; Cha K.Y.

Imaging of the metaphase spindle in vitrified human and mouse oocytes matured in vitro
pp. 143-144(2)
Authors: Neri Q.V.; Takeuchi T.; Rosenwaks Z.; Palermo G.D.

Assisted hatching at the time of warming improves the implantation rate of vitrified human blastocysts (BLs)
pp. 144-144(1)
Authors: Mukaida T.; Tomiyama T.; Oka C.; Goto T.; Kasai M.; Takahashi K.

Novel use of an aromatase inhibitor for fertility preservation via embryo cryopreservation in endometrial cancer: a case report
pp. 144-144(1)
Authors: Oktay K.H.; Buyuk E.; Rosenwaks Z.

A model to assess the protective effect of antioxidants from ischemia after ovarian transplantation
pp. 144-144(1)
Authors: Kim S.S.; Kang H.; Lee H.-H.; Lee H.-C.; Ko D.-S.; Kim J.

High pregnancy rates can be achieved after freezing and thawing human blastocysts
pp. 145-145(1)
Authors: Veeck L.L.; Bodine R.; Clarke R.N.; Berrios R.; Zaninovic N.; Rosenwaks Z.

Comparison of efficacy of different cryoprotectant solutions for mouse ovarian tissue
pp. 145-145(1)
Authors: Pal L.; Kayisli U.A.; Ergur A.R.; Cohen H.; Mor G.; Palter S.

Vitrification demonstrates significant improvement over conventional slow freezing of day 5 blastocysts
pp. 145-146(2)
Authors: Stehlik J.; Stehlik E.; Katayama K.P.; Kuwayama M.; Brohammer R.; Jambor V.

Cryopreservation of supernumerary day-3 embryos with poor quality: is there any benefit for extending culture to blastocyst before freezing?
pp. 146-146(1)
Authors: Esfandiari N.; Casper R.F.; Moskovtsev S.; Javed M.; Claessens E.A.; Gotlieb L.

Sperm glutathione antioxidant defense system protects from cryodamage after a cycle of freezing and thawing
pp. 146-146(1)
Authors: Meseguer M.; Garrido N.; Rodriguez M.; Simon C.; Pellicer A.; Remohi J.

Prospective randomized comparison between transfer of blastocyst stage embryos and cleavage stage embryos during frozen cycles after ICSI procedure
pp. 146-147(2)
Authors: Azim A.M.A.; Khan I.; Fakih M.H.; Shamma F.N.; Ayres J.W.T.; Abuzeid M.I.

Improved outcome of frozen-thawed blastocyst transfer with Menezo's 2-step thawing protocol
pp. 147-147(1)
Authors: Ding J.; Shen M.; Rana N.; Dmowski W.P.

Optimization of a thawing method for human expanded blastocysts vitrified using EM-Grid after artificial shrinkage
pp. 147-148(2)
Authors: Lee S.-Y.; Jae B.-S.; Lee S.-Y.; Son W.-Y.; Yoon S.-H.; Lim J.-H.

Freezing of human immature oocytes using cryoloops with Taxol in the vitrification solution
pp. 148-148(1)
Authors: Fuchinoue K.; Kyono K.; Fukunaga N.; Nakajo Y.; Yagi A.; Sasaki S.

Intracellular sperm and seminal plasma Ca+2 concentrations affect cryodamage susceptibility after a cycle of freezing and thawing
pp. 148-148(1)
Authors: Meseguer M.; Garrido N.; Antonio Martinez J.; Simon C.; Pellicer A.; Remohi J.

Cryoprotectant induced lipid peroxidation in spermatozoa being processed for freezing
pp. 148-149(2)
Authors: Vartorella H.A.; Prien S.D.

Blastocyst cryopreservation: an update
pp. 149-149(1)
Authors: Behr B.; Gebhardt J.; Milki A.A.

A healthy female born after ICSI of a cryopreserved oocyte and cryopreserved spermatozoa banked prior to radiotherapy in a patient with a seminoma: a case report
pp. 149-149(1)
Authors: Notrica J.; Kanzepolsky L.; Divita A.; Neuspiller F.; Fried E.P.d.

Apoptosis in cryopreserved ovarian tissue-a tool of evaluation cryopreservation utility
pp. 149-149(1)
Authors: Rimon E.; Cohen T.; Amsterdama A.; Amit A.; Lessing J.; Azem F.

Comparison of slow freezing in the cleavage stage and ultra-rapid vitrification of blastocysts
pp. 149-150(2)
Authors: Tanaka M.; Yoshida A.; Suzuki H.; Takahashi A.; Seida K.; Fujimori T.

Extending culture of frozen-thawed, cleavage stage embryos to blastocyst stage achieves higher pregnancy and implantation rates when compared to overnight culture
pp. 150-150(1)
Authors: Ampeloquio E.; Adler A.; Lee J.; Krey L.; Grifo J.

Frozen blastocyst transfer: a five year evaluation of controlled rate cryopreservation technique
pp. 150-151(2)
Authors: Langley M.T.; Marek D.E.; Nackley A.C.; Doody K.M.; Doody K.J.

Timing of blastocyst transfer relative to the thaw: a critical factor in outcome following FET
pp. 151-151(1)
Authors: Adamowicz M.; Keskintepe L.; Zody R.; Danner L.; Fisch J.D.; Sher G.

Cryopreserved blastocyst survival post preimplantation genetic diagnosis
pp. 151-151(1)
Authors: Anderson A.R.; Crain J.L.

The viability of day 6 blastocyst stage embryos compared to day 5 blastocyst stage embryos
pp. 151-151(1)
Authors: Yoon S.-H.; Lee S.-Y.; Yoon H.-J.; Jae B.-S.; Son W.-Y.; Lim J.-H.

Embryos frozen at the 2PN stage demonstrate a reduced number of cells at the third day compared with fresh embryos of the same cycles
pp. 152-152(1)
Authors: Levin I.; Schwartz T.; Mey-Raz N.; Malcov M.; Ben-Yosef D.; Amit A.

Abnormal sperm DNA condensation is associated with low fertilization rate in IVF
pp. 152-152(1)
Authors: Powers R.D.; Alper M.M.; Hayes M.; Shai S.; Fihman G.

Outcome of recipients with and without ovarian function
pp. 152-152(1)
Authors: Graziano V.; Check J.H.; Lurie D.; Wilson C.

Intra-Uterine Insemination (IUI) outcome is enhanced by shorter intervals from semen collection to sperm wash, from sperm wash to IUI time, and from semen collection to IUI time
pp. 152-153(2)
Authors: Yavas Y.; Selub M.R.; Lefkow H.; Carmichael D.

Two versus three embryos for transfer on day 3: influence of female age and embryo quality on outcome
pp. 153-153(1)
Authors: Stassart J.P.; Castillo R.; Ball G.D.

Determining factors of early embryo cleavage to 2-cell stage for predicting the pregnancy outcome of in vitro fertilization
pp. 153-153(1)
Authors: Joo B.S.; Moon H.S.; Park S.H.; Lee S.K.; Lee M.S.; Kim K.S.

Examination of pronuclear patterns in a cohort of embryos selected for transfer on the basis of day 3 embryo score
pp. 153-154(2)
Authors: Desai N.; Kattal N.; Goldfarb J.

Is attempting blastocyst transfer a good idea for women at advanced maternal ages?
pp. 154-154(1)
Authors: Asakura H.; Stehlik E.F.; Stehlik J.C.; Katayama K.P.

What is the lower threshold of clinical response for donor cycle cancellation? relationship of clinical response, oocyte number, and success in donor cycles
pp. 154-155(2)
Authors: Letterie G.S.; Marshall L.; Angle M.

Transferring 2 or 3 embryos in women 35 to 37 years old: influence of embryo quality and number of previous cycles on pregnancy and multiple pregnancy rates
pp. 155-155(1)
Authors: Schmidt D.; Nulsen J.; Benadiva C.; Siano L.; Maier D.

Is that any value in treating women with elevated basal follicular stimulating hormone?
pp. 155-155(1)
Authors: Thum M.-Y.; Abdalla H.; Wren M.; Ogunyemi T.; Faris R.; Gafar A.

The influence of body mass index on in vitro fertilization treatment outcome, risk of miscarriage, and pregnancy outcome
pp. 155-156(2)
Authors: Thum M.-Y.; Gafar A.; Faris R.; Wren M.; Ogunyemi T.; Abdalla H.

Relationships of embryo cell number and degree of fragmentation on day 3 with blastocyst formation and implantation rates
pp. 156-156(1)
Authors: Zhang X.J.; Horan K.; Barnes R.; Confino E.; Milad M.; Kazer R.

Ovarian reserve and cycle number predict success of superovulation and intrauterine inseminations
pp. 156-157(2)
Authors: Goudas V.T.; Jindal S.K.; Chudnoff S.; Witt B.R.; Barad D.H.; Santoro N.F.

The use of recombinant (r) FSH in in vitro fertilization (IVF) may be associated with lower implantation rate
pp. 157-157(1)
Authors: Minaretzis D.; Michas P.; Barnes C.

Number of matured oocytes is a better predictor of pregnancy than age in women under 38 years of age
pp. 157-158(2)
Authors: Abdelmassih V.; Oliveira F.G.; Melo N.R.; Diamond M.P.; Abdelmassih R.; Dozortzev D.

Follicular diameter and hCG administration do not affect pregnancy rates after clomiphene citrate and intrauterine insemination
pp. 158-158(1)
Authors: Coker L.; Lawler C.; Zhao Y.; Bankowski B.; Wallach E.; Vlahos N.

Clomid citrate challenge test identifies more poor responders than day 3 FSH in patients over 35 years
pp. 158-158(1)
Authors: Catherino W.H.; Klipstein S.; McKeeby J.; Segars J.H.

Does the inclusion of low quality embryos at the moment of transfer interfere in in vitro fertilization results?
pp. 158-159(2)
Authors: Michelon J.; Boeno A.; Azambuja R.; Badalotti M.; Badalotti F.; Petracco A.

Characteristics of in vitro fertilization laboratories accredited by various agencies
pp. 159-159(1)
Authors: Mahadevan M.; Miller M.

A history of failed blastocyst-stage embryo transfer does not diminish the beneficial effect of blastocyst transfer in a subsequent cycle
pp. 159-159(1)
Authors: Miller K.A.; Elkind-Hirsch K.E.; Bergh P.A.; Scott R.T.

Predictive value of the differential in nucleolar count (ND) between the pronuclei of 16-18 hour zygote and embryo quality on day 3 and 5
pp. 159-160(2)
Authors: Brusil I.; Keskintepe L.; Adamowicz M.; Zody R.; Fisch J.D.; Sher G.

Morbid obesity adversely impacts outcomes with IVF
pp. 160-160(1)
Authors: Doody K.M.; Langley M.T.; Marek D.E.; Nackley A.C.; Doody K.J.

A computerized model for prediction of repeated implantation failure in IVF-ET
pp. 160-160(1)
Authors: Levran D.; Biran G.; Farhi J.; Nahum H.; Glezerman M.; Weissman A.

A mathematical equation to calculate the maximum pregnancy rate with a minimum risk for multiple pregnancies in patients undergoing IVF
pp. 160-161(2)
Authors: Rodriguez M.; Escudero E.; Epifanio R.; Garrido N.; Messeger M.; Simon C.

Can ICSI be used to improve cycle outcome for patients with a high incidence of triploidy in a previous IVF cycle?
pp. 161-161(1)
Authors: O'Leary T.F.; Jackson K.V.; Combelles C.; Penachio D.; Racowsky C.

Grade 1 and 2 cleaving embryo transfer is comparable to blastocyst transfer
pp. 161-161(1)
Authors: Hurst B.S.; Hurst K.M.; Papadakis M.A.; Matthews M.M.; Marshburn P.B.

Altered sex ratios and increased monozygotic twinning in babies born following day 6 blastocyst transfers in human IVF-ET
pp. 161-162(2)
Authors: Roots E.H.; Smith K.; Dorsett J.O.

A history of elevated basal Follicle Stimulating Hormone (FSH) elevations is predictive of in vitro fertilization (IVF) outcome
pp. 162-162(1)
Authors: Roberts J.E.; Spandorfer S.D.; Fasouliotis S.J.; Rosenwaks Z.

Blastomere multinucleation and subsequent preembryo development
pp. 162-163(2)
Authors: Cook C.A.; Clarke R.; Ye Z.; Berrios R.; Veeck L.L.; Zaninovic N.

Comparison between Total Antioxidant Status (TAS), Reactive Oxygen Species (ROS) and DNA integrity of IVF and ICSI patients and their predictive value of IVF/ICSI outcome
pp. 163-163(1)
Authors: Hammadeh M.; Al-Hasani S.; Spengler C.; Rosenbaum P.; Schmidt W.

Comparison of follicular blood flow and follicular fluid concentrations of vascular endothelial growth factor and nitric oxide as prognostic factors in the outcome of in vitro fertilization
pp. 163-163(1)
Authors: Lee K.S.; Oh D.S.; Kim K.H.; Kim W.H.

Effect of day 2 multinucleation on human embryo development
pp. 163-163(1)
Authors: Prados N.; Crespo M.; Hernaez M.J.; Mantrana E.; Navarro J.; Calderon G.

Availability of supernumerary embryos allows meaningful selection even at the blastocyst stage
pp. 163-164(2)
Authors: Miller K.A.; Elkind-Hirsch K.E.; Scott R.T.

Endometrial thickness and serum oestradiol serum level as predictors of success in oocyte donation
pp. 164-164(1)
Authors: Troncoso C.; Bosch E.; Epifanio R.; Simon C.; Pellicer A.; Remohi J.

Surveillance of physical and mental development of children after IVF-ET
pp. 164-164(1)
Authors: Nakajo Y.; Kyono K.; Fukunaga N.; Fuchinoue K.; Yagi A.; Sasaki S.

Influence of the position of the culture dish within the incubator chamber and temperature of culture media on clinical outcome following Assisted Reproductive Technology (ART) treatment
pp. 164-165(2)
Authors: Stoddart N.R.; Rho H.C.; Maisel L.P.; Zhao T.-H.; Tarantino S.; Fleming S.D.

Elevated estradiol levels in oocyte donation cycles do not impair art outcomes for the recipients
pp. 165-165(1)
Authors: Bianco K.; Mahutte N.G.; Arici A.; Duleba A.J.; Taylor H.S.; Sakkas D.

Endocrine and ultrasonographic assessment of the ovarian reserve and their predictive potential for IVF outcome
pp. 165-165(1)
Authors: Cabrera R.A.; Wong B.C.; Bocca S.; Stadtmauer L.A.; Gibbons W.E.; Oehninger S.

The Graduated Embryo Score (GES) on day 3 of culture predicts outcome from blastocyst transfer
pp. 165-166(2)
Authors: Fisch J.D.; Sher G.; Adamowicz M.; Zody R.; Keskintepe L.

Magnitude of the decline in random day 3 FSH levels following leuprolide acetate-induced pituitary down-regulation and its effect on stimulation quality in IVF
pp. 166-166(1)
Authors: Fasouliotis S.J.; Kowalik A.; Roberts J.E.; Liu H.-C.; Rosenwaks Z.

Do early cleavage-stage embryos demonstrate a culture media preference?
pp. 166-166(1)
Authors: Dudkiewicz A.; Poole E.; Novotny M.; Zhu J.-J.; Kim H.; Cohen D.

AUC (Area under the Curve) for Estradiol (E2) predicts treatment outcome in women undergoing IVF-ET (In Vitro Fertilization and Embryo Transfer)
pp. 166-167(2)
Authors: Mitwally M.F.M.; Bhakoo H.S.; Crickard K.; Sullivan M.W.; Batt R.E.; Yeh J.

Increased implantation rates with day 5 transfers only occurs in selected sub-groups
pp. 167-167(1)
Authors: Thyer A.; Khabani A.; Tufts K.; Craig L.; Scott L.

Follicular reactive oxygen species in relation to oocyte maturity and fertilization outcome
pp. 167-168(2)
Authors: Aboul Enien W.M.A.; Lewis-Jones I.D.

Type of donor frozen sperm does not affect Intra-Uterine Insemination (IUI) outcome
pp. 168-168(1)
Authors: Yavas Y.; Selub M.R.; Lefkow H.; Carmichael D.

Effect of culture system upon fertilization rate and embryo development for patients 40 years and older
pp. 168-168(1)
Authors: Mortimer S.T.; Fluker M.R.; Yuzpe A.A.

Ovarian stimulation with Human Menopausal Gonadotropin (HMG) is more effective than Clomiphene Citrate (CC) in Intra-Uterine Insemination (IUI) using partner's sperm, but not in IUI using donor frozen sperm
pp. 168-169(2)
Authors: Yavas Y.; Selub M.R.; Lefkow H.; Carmichael D.

Regardless of oocyte source, body mass index is predictive of in vitro fertilization success
pp. 169-169(1)
Authors: Merryman D.C.; Yancey C.A.; Dalton K.E.; Houserman V.L.; Long C.A.; Honea K.L.

Multiple attempts at embryo transfer is associated with decreased rates of embryo implantation and clinical pregnancy with regard to in vitro fertilization
pp. 169-169(1)
Authors: Yoshida A.; Tanaka M.; Suzuki H.; Takahashi A.; Seida K.; Fujimori T.

Risk factors associated with preclinical pregnancy loss following ART
pp. 169-170(2)
Authors: Hur K.; Yang K.M.; Kim J.Y.; Song I.O.; Jun J.Y.; Kang I.S.

IVF success in patients 41 years and older with an elevated day 3 FSH is impacted by the number of cycle attempts
pp. 170-170(1)
Authors: Bendikson K.A.; Jackson K.V.; Yanushpolsky E.H.; Ginsburg E.S.; Racowsky C.

Repeat oocyte donor cycles: Factors from the initial cycle which predict outcome in subsequent cycles
pp. 170-170(1)
Authors: Gopal M.; Gutmann J.N.; Batzer F.R.; Gocial B.; Kelly M.P.

The impact of seasonal variations on fertilization rate, embryo quality, and pregnancy rates during intracytoplasmic sperm injection
pp. 170-171(2)
Authors: Mercan R.; Mumcu A.; Isiklar A.; Balaban B.; Alatas C.; Urman B.

The effect of multiple cycles in oocyte donors
pp. 171-171(1)
Authors: Jain A.; Lin J.P.; Robins J.C.; Williams D.B.; Eckert J.; Thomas M.A.

Low-dose gonadotropin step-up protocol is highly successful for the PCOS patient
pp. 171-171(1)
Authors: Shamonki M.I.; Spandorfer S.D.; Roberts J.E.; Fasouliotis S.J.; Rosenwaks Z.

Anonymous donors 32 years and older have reduced clinical pregnancy rates and fewer cryopreserved embryos
pp. 171-172(2)
Authors: Craig L.B.; Thyer A.; Hansen K.R.; Waibel L.L.; Scott L.; Klein N.A.

Does a failed blastocyst IVF cycle predict future cycle outcome?
pp. 172-172(1)
Authors: Wayman M.; Kennard E.A.

No correlation of follicular fluid concentration of vascular endothelial growth factor and nitric oxide with the pregnancy outcome as well as the age of women undergoing in vitro fertilization
pp. 172-172(1)
Authors: Joo B.S.; Lee K.S.; Park S.H.; Lee S.K.; Moon H.S.

Oocytes quality revisited: No correlation between oocytes morphology and ICSI outcome
pp. 172-172(1)
Authors: Lamandin E.E.L.; Du A.A.L.L.; Fanchin R.R.F.; Frydman R.R.F.; Tachdjian G.G.T.; Frydman N.N.F.

Serum hCG levels 12 days after embryo transfer is predictive of pregnancy outcome
pp. 172-172(1)
Authors: Hotamisligil S.; Carson R.; Glatstein I.; Pang S.; McShane P.

Type of infertility is a prognostigator of IVF outcome
pp. 172-173(2)
Authors: Pal L.; Cohen H.; Witt B.R.

Day 28 serum Beta-hCG levels and early pregnancy outcome
pp. 173-173(1)
Authors: Keegan D.A.; Krey L.C.; Grifo J.A.

Ectopic pregnancy rates with day 3 versus day 5 embryo transfer
pp. 173-174(2)
Authors: Jun S.H.; Milki A.A.

The balance between optimizing recipient pregnancy outcomes and aggressive oocyte donor stimulation. How many oocytes are enough?
pp. 174-175(2)
Authors: Meintjes M.; Chantilis S.; Ward D.; Madden J.; Bookout D.; Douglas J.

Adverse impact of increasing body mass on pre-egg retrieval serum Human Chorionic Gonadotropin (HCG) levels
pp. 174-174(1)
Authors: Doody K.M.; Marek D.E.; Langley M.T.; Nackley A.C.; Doody K.J.

Impact of the number of 8-cell embryos at fresh and frozen embryo transfer on the outcome with respect to the german embryo protection law
pp. 174-174(1)
Authors: Liebermann J.; Tweraser K.; Blissing S.; Mulfinger L.; Liebermann M.; Dietl J.

Assisted reproduction and risk of birth defects
pp. 175-175(1)
Authors: Olson C.K.; Syrop C.H.; Dokras A.; Sparks A.E.T.; Davis W.A.; Voorhis B.J.V.

Factors affecting obstetrical choices in high order multiple pregnancy patients after undergoing in vitro fertilization and embryo transfer
pp. 175-176(2)
Authors: Berrios R.; Clarke R.N.; Zaninovic N.; Ye Z.; Veeck L.L.

Prolongued coasting duration affects implantation rates
pp. 176-176(1)
Authors: Garcia-Velasco J.A.; Moreno L.; Zuniga A.; Villasante A.; Requena A.; Pellicer A.

High Order Multiple (HOM) pregnancies and IVF cycle number: is there an association?
pp. 176-176(1)
Authors: Klipstein S.; Eyvazzadeh A.; Thornton K.L.; Timmreck L.S.; Ryley D.A.; Reindollar R.H.

Effect of TNF- blocker (Infliximab) on blastocyst development rate
pp. 176-177(2)
Authors: Noriega J.; Bedaiwy M.A.; Sharma R.K.; Agarwal A.; Falcone T.

Elective fresh transfer of one or two embryos
pp. 177-177(1)
Authors: Marek D.E.; Langley M.T.; Howell J.R.; Nackley A.C.; Doody K.M.; Doody K.J.

Cytogenetic analysis in fetuses from spontaneous abortions after In Vitro Fertilization (IVF) by comparative genomic hybridization
pp. 177-177(1)
Author: Tan Y.

Ectopic pregnancy in IVF with own versus donated oocytes
pp. 177-178(2)
Authors: Molina N.M.; Bosch E.; Troncoso C.; Simon C.; Pellicer A.; Remohi J.

High incidence of ectopic pregnancy following frozen embryo transfer
pp. 178-178(1)
Authors: Silva C.; Trimarchi J.; Keefe D.; Frankfurter D.

Outcome of pregnancies complicated by moderate and severe OHSS: a follow up beyond the second trimester
pp. 178-178(1)
Authors: Wiser A.; Kreiser D.; Levron J.; Dor J.; Schiff E.; Shulman A.

Does extreme obesity have an impact on ovarian response and outcome of infertile women included in an IVF program?
pp. 178-179(2)
Authors: Avril C.; Bastite L.; Chaput-Toupin E.; Villiere J.

Does ICSI cause an increase in fetal abnormalities and obstetrical complications?
pp. 179-179(1)
Authors: Khabani A.; Craig L.; Lin P.C.; Soules M.R.; Scott L.

Timing of presentation with severe OHSS predicts clinical IVF pregnancy
pp. 179-179(1)
Authors: Van Nest R.L.; Stillman R.J.; Richter K.S.

Increased second trimester pregnancy loss following In Vitro Fertilization (IVF)
pp. 179-180(2)
Authors: Keltz M.D.; Sharma P.; Stein D.E.

Elective single blastocyst transfer
pp. 180-180(1)
Authors: Milki A.A.; Littman E.D.; Hinckley M.D.; Westphal L.M.; Gebhardt J.; Behr B.

Biochemical pregnancy and miscarriage rates for fresh and frozen cycles following extended embryo culture in non-selected patients
pp. 180-180(1)
Authors: Marek D.E.; Langley M.T.; Nackley A.C.; Doody K.M.; Doody K.J.

Reducing the risk and economic impact of High Order Multiple (HOM) gestations by the use of blastocysts at the time of embryo transfer
pp. 180-181(2)
Authors: Alvero R.J.; McKeeby J.; Segars J.; Miller B.T.; Nieman L.; Armstrong A.Y.

Recombinant Human Chorionic Gonadotropin (RHCG): a comparison of 250 versus 400 mcg doses
pp. 181-181(1)
Authors: Klipstein S.; Alper M.M.

Highly purified (hp)-hMG versus urinary (u)-hMG: a randomized study in oocyte donors
pp. 181-181(1)
Authors: Giles J.M.; Requena A.; Garcia-Velasco J.A.; Guillen A.; Remohi J.

Effect of length of stimulation in ART cycles on pregnancy rate
pp. 181-182(2)
Authors: Ivani K.A.; Weckstein L.N.; Walker D.M.

Effect of GnRH antagonists on cancellation rates in IVF cycles
pp. 182-182(1)
Authors: Prough S.G.; Blackwell J.L.; McNichol M.W.; Thibodeaux J.K.; Green H.; Moseley R.

Oocyte number per livebirth in IVF: were Steptoe and Edwards less wasteful?
pp. 182-183(2)
Author: Inge G.B.

Oral contraceptive pretreatment for scheduling in IVF patients treated with either rFSH/GnRH Antagonist or rFSH/GnRH agonist
pp. 183-183(1)
Authors: Dickey R.P.; Chantilis S.J.; Hurst B.S.; Barmat L.I.

Phase III German Multicenter Study to evaluate the convenience and the safety of a multidose formulation of follitropin- alfa (Gonal-F(R)) designed for self-administration by the patient
pp. 183-183(1)
Authors: Naether O.G.J.; Huebner S.; Bilger W.

Flexible use of the GnRH antagonist, ganirelix, according to ultrasound follicular development, in women undergoing controlled ovarian hyperstimulation with recombinant FSH. a multi-center clinical survey
pp. 183-184(2)
Authors: Argentinean Orgalutran Study Group; Sobral F.L.

Should we increase the gonadotrophin dose with the onset of the GnRH antagonist?
pp. 184-184(1)
Authors: Guillen A.; Requena A.; Giles J.; Moreno L.; Garcia Velasco J.A.; Pellicer A.

Failure of serum estradiol level rise in the late follicular phase is predictive of lower pregnancy rates in donor oocyte In Vitro Fertilization (IVF) cycles
pp. 184-184(1)
Authors: Wright G.; Ng F.L.; Jones A.E.; Nagy Z.P.

The elimination of Estradiol (E2) monitoring during controlled ovarian hyperstimulation (COH) with intrauterine insemination (IUI) will lead to acceptable pregnancy rates without an increase in high order multiple gestation or ovarian hyperstimulation syndrome (OHSS)
pp. 184-184(1)
Authors: Rodriguez C.; Strawn E.Y.; Karcaaltincabal D.; Reinke M.; Lehman P.; Eastwood D.

Comparison of GnRH agonist and GnRH antagonist in ovarian stimulation of oocyte donors
pp. 185-185(1)
Authors: Saucedo-de la Llata E.; Moraga S.M.R.; Batiza R.V.; Santos H.R.; Galache V.P.; Hernandez-Ayup S.; Patrizio P.

A randomized, assessor-blind, multicentre study to investigate the efficacy and efficiency of a starting dose of 100IU or 200IU of recombinant follicle stimulating hormone (Puregon(R)) in women undergoing controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer treatment
pp. 185-185(1)
Authors: Tan S.L.; Child T.J.; Cheung P.; Fluker M.; Casper R.; Davis V.

Embryologic and clinical outcomes of donor oocyte IVF cycles using Ovidrel (rhCG) versus profasi (uhCG) for follicular triggering after a standard downregulation protocol
pp. 185-185(1)
Authors: Marut E.L.; Kaplan B.R.; Coughlin C.W.

The impact of various controlled ovarian hyperstimulation protocols on blastocyst formation
pp. 185-186(2)
Authors: Sandler B.; Copperman A.; Duke M.; Mukherjee T.; Bergh P.; Barritt J.

Comparison of different follicular diameters at initiation of GnRH antagonists in ART cycles
pp. 186-186(1)
Authors: Kenny A.; Inza R.; Londra L.; Lombardi E.; Young E.; Sueldo C.

Ganirelix can be used to restore normal expectation of pregnancy in patients experiencing premature luteinization in Controlled Ovarian Hyperstimulation (COH) cycles for Intrauterine Insemination (IUI)
pp. 186-186(1)
Authors: Shapiro D.; Brown V.; Carter M.; Roudebush W.

The relationship between follicular fluid hormone levels, embryo quality and maternal age with in vitro fertilization after either the short or long protocol using a GnRH agonist
pp. 186-187(2)
Author: Araki Y.

Effect of different doses of hCG on IVF outcomes
pp. 187-187(1)
Authors: Kang H.-J.; Rosenwaks Z.; Schattman G.

A four-year study of clomiphene citrate challenge test results
pp. 187-187(1)
Authors: Miller J.W.; Hill G.A.; Whitworth C.M.; Weitzman G.A.; Eblen A.C.; Freeman M.R.

Baseline and cycle day 5 inhibin-b levels are useful adjuncts in assessing ovarian reserve of women of advanced reproductive age
pp. 187-188(2)
Authors: Ruman J.; Ferin M.; Thornton M.H.; Pena J.E.; Kavic S.M.; Sauer M.V.

IVF-ET using naturally-selected dominant follicle for poor prognosis patients: a hypothesis
pp. 188-188(1)
Authors: Kadoch J.J.K.; Frydman N.N.F.; Branco A.A.C.C.; Bataille N.N.L.L.; Fanchin R.R.F.; Frydman R.R.F.

Comparison of GnRH antagonist cycles with and without oral contraceptive pill pretreatment in poor responders
pp. 188-189(2)
Authors: Bendikson K.; Milki A.A.; Speck-Zulak A.; Westphal L.M.

Novel method of ovulation induction for the patients who have resistance to gonadotropin administration
pp. 189-189(1)
Authors: Aisaka K.; Doi M.; Sasaki Y.; Shittaka N.; Obata S.; Foulk R.A.

GnRH antagonist compares favorably, but is not superior, to GnRH agonist microflare for poor responders in IVF
pp. 189-189(1)
Authors: Retzloff M.G.; Jackson K.V.; Ashby R.K.; Guarnaccia M.M.; Ginsburg E.S.; Racowsky C.

Luteal phase estradiol supplementation improves In Vitro Fertilization (IVF) pregnancy rates in low responders
pp. 189-190(2)
Authors: Ziegler W.F.; Miller J.; Kratka S.A.

Recombinant Follicle Stimulation Hormone (RFSH) and Human Menopausal Gonadotropin (HMG) provides a higher clinical pregnancy rate in low responders undergoing IVF compared to RFSH alone
pp. 190-190(1)
Authors: Ziegler W.F.; Sainez J.; Kratka S.A.

Clinical and endocrine impact of pretreatment with oral contraceptive pills in poor responders undergoing IVF with a combination of microdose flare leuprolide acetate and high dose gonadotropins
pp. 190-191(2)
Authors: Mirkin S.; Stadtmauer L.A.; Gibbons W